// Auto-generated from Moneyball 2025.xlsx â€” AI summaries added by generateSummaries.mjs
export const SAMPLE_DATA = [
  {
    "id": 1,
    "category": "Adaptive Clothing",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 1780509,
    "marketGrowth": 10.27,
    "marketShare": 0.94,
    "mmsGpDollars": 8602,
    "mmsGpMargin": 37.52,
    "mmsGrowth": null,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": null,
    "mbVsMmsGp": null,
    "nbSales": 22924,
    "summary": {
      "headline": "Zero MB sales in growing market with untapped potential.",
      "pros": [
        "Market growing at 10.3% annually",
        "Untapped potential quadrant indicates opportunity",
        "NB competitors earning 37.5% gross profit"
      ],
      "cons": [
        "McKesson has zero sales and zero penetration",
        "Low MMS market share at 0.9%",
        "No MB growth data or competitive presence"
      ]
    }
  },
  {
    "id": 2,
    "category": "Ancillary Nursing Supplies",
    "tier": null,
    "penetration": 58.66,
    "coverage": 2.58,
    "totalMarket": 632171521,
    "marketGrowth": 5.68,
    "marketShare": 8.53,
    "mmsGpDollars": 7861717,
    "mmsGpMargin": 32.22,
    "mmsGrowth": -3.27,
    "revenue": 34617798,
    "mbGpDollars": 15009218,
    "mbGpMargin": 43.36,
    "mbGrowth": 8.13,
    "mbOutpaceMms": 11.4,
    "mmsOutpaceMarket": null,
    "mbVsMmsGp": 11.14,
    "nbSales": 24400896,
    "summary": {
      "headline": "Strong margins and growth, but limited market opportunity constrains tier ranking.",
      "pros": [
        "MB outpacing NB growth by 11.4 percentage points significantly",
        "43.4% gross profit margin substantially exceeds NB at 32.2%",
        "8.1% MB growth outpaces market growth of 5.7%"
      ],
      "cons": [
        "Very low coverage at 2.6% limits expansion potential",
        "Only 59% penetration indicates significant untapped customer base",
        "Small $34.6M sales base constrains overall revenue impact"
      ]
    }
  },
  {
    "id": 3,
    "category": "Anesthesia & Suction",
    "tier": null,
    "penetration": 19.81,
    "coverage": 2.14,
    "totalMarket": 639109750,
    "marketGrowth": 6.56,
    "marketShare": 8.27,
    "mmsGpDollars": 13396219,
    "mmsGpMargin": 24.63,
    "mmsGrowth": -0.87,
    "revenue": 13439717,
    "mbGpDollars": 5632210,
    "mbGpMargin": 41.91,
    "mbGrowth": 8.13,
    "mbOutpaceMms": 9.01,
    "mmsOutpaceMarket": -4.38,
    "mbVsMmsGp": 17.28,
    "nbSales": 54392161,
    "summary": {
      "headline": "Strong MB growth with massive untapped market opportunity despite low penetration.",
      "pros": [
        "MB outpacing NB by 9.0% with 8.1% growth rate",
        "Superior 41.9% gross profit margin vs NB 24.6%",
        "Large addressable market of $639.1M with only 20% penetration"
      ],
      "cons": [
        "Very low coverage at 2.1% limits growth potential near-term",
        "MB represents only 8.3% of total market share",
        "Untapped potential requires significant investment to convert coverage"
      ]
    }
  },
  {
    "id": 4,
    "category": "Automation System",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 658379,
    "marketGrowth": -45.73,
    "marketShare": 94.79,
    "mmsGpDollars": 27190,
    "mmsGpMargin": 27.26,
    "mmsGrowth": -44.85,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": 0.88,
    "mbVsMmsGp": null,
    "nbSales": 99749,
    "summary": {
      "headline": "Tier 5: Zero MB sales in declining market with dominant competitor.",
      "pros": [
        "Untapped potential with zero current penetration",
        "MMS strong market position at 94.8% share",
        "NB maintains healthy 27.3% gross margin"
      ],
      "cons": [
        "Market declining sharply at -45.7% year-over-year",
        "Zero McKesson Brands sales and presence",
        "MMS dominance leaves minimal opportunity for MB"
      ]
    }
  },
  {
    "id": 5,
    "category": "Beds and Patient Safety",
    "tier": null,
    "penetration": 9.64,
    "coverage": 1.89,
    "totalMarket": 747721332,
    "marketGrowth": 12.02,
    "marketShare": 4.49,
    "mmsGpDollars": 7911803,
    "mmsGpMargin": 18.15,
    "mmsGrowth": 10.03,
    "revenue": 4651186,
    "mbGpDollars": 1583529,
    "mbGpMargin": 34.05,
    "mbGrowth": 4.19,
    "mbOutpaceMms": -5.84,
    "mmsOutpaceMarket": -1.62,
    "mbVsMmsGp": 15.9,
    "nbSales": 43592735,
    "summary": {
      "headline": "Strong margins and market growth mask lagging MB momentum and low penetration.",
      "pros": [
        "High gross profit margin (34.0%) vs NB (18.1%)",
        "Large addressable market ($747.7M) with healthy growth (12.0%)",
        "Untapped potential with only 10% penetration rate"
      ],
      "cons": [
        "MB growth (4.2%) significantly trails market (12.0%)",
        "Low coverage (1.9%) indicates limited customer reach",
        "MB underperforming NB by -5.8% growth gap"
      ]
    }
  },
  {
    "id": 6,
    "category": "BioMed",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": null,
    "marketGrowth": null,
    "marketShare": null,
    "mmsGpDollars": -16800,
    "mmsGpMargin": 100,
    "mmsGrowth": null,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": null,
    "mbVsMmsGp": null,
    "nbSales": -16800,
    "summary": {
      "headline": "No McKesson brand sales; significant untapped market opportunity.",
      "pros": [
        "Zero cannibalization risk to existing portfolio",
        "Greenfield opportunity for category expansion",
        "High NB gross margin indicates viable market"
      ],
      "cons": [
        "Requires investment to build brand presence",
        "Unknown market size and growth trajectory",
        "No established McKesson footprint or awareness"
      ]
    }
  },
  {
    "id": 7,
    "category": "Compression",
    "tier": null,
    "penetration": 28.09,
    "coverage": 3.5,
    "totalMarket": 44125159,
    "marketGrowth": 2.08,
    "marketShare": 11.22,
    "mmsGpDollars": 1284947,
    "mmsGpMargin": 32.88,
    "mmsGrowth": 3.89,
    "revenue": 1526492,
    "mbGpDollars": 591709,
    "mbGpMargin": 38.76,
    "mbGrowth": -7.34,
    "mbOutpaceMms": -11.23,
    "mmsOutpaceMarket": 0.39,
    "mbVsMmsGp": 5.88,
    "nbSales": 3907857,
    "summary": {
      "headline": "Selective winner with strong margins but declining sales requires urgent intervention.",
      "pros": [
        "Strong GP% advantage over NB at 38.8%",
        "Solid market position with 11.2% MMS share",
        "Established presence with 28% penetration"
      ],
      "cons": [
        "Significant MB sales decline of -7.3% YoY",
        "Underperforming NB by 11.2 percentage points",
        "Low coverage at 3.5% limits growth potential"
      ]
    }
  },
  {
    "id": 8,
    "category": "Containers",
    "tier": null,
    "penetration": 43.68,
    "coverage": 5.39,
    "totalMarket": 149962096,
    "marketGrowth": 3.36,
    "marketShare": 28.88,
    "mmsGpDollars": 7096331,
    "mmsGpMargin": 23.46,
    "mmsGrowth": -0.06,
    "revenue": 23461996,
    "mbGpDollars": 9284295,
    "mbGpMargin": 39.57,
    "mbGrowth": 6.31,
    "mbOutpaceMms": 6.36,
    "mmsOutpaceMarket": -2.73,
    "mbVsMmsGp": 16.11,
    "nbSales": 30247227,
    "summary": {
      "headline": "Strong MB growth and margin leadership, but limited market penetration opportunity.",
      "pros": [
        "MB outpacing NB growth by 6.4% significantly",
        "Superior GP% advantage: 39.6% vs NB 23.5%",
        "Assortment Leader with proven McKesson Champions status"
      ],
      "cons": [
        "Low penetration at 44% limits expansion potential",
        "Minimal coverage at 5.4% across customer base",
        "Modest market growth of 3.4% constrains category"
      ]
    }
  },
  {
    "id": 9,
    "category": "CPAP",
    "tier": null,
    "penetration": 0.01,
    "coverage": 0.06,
    "totalMarket": 241288964,
    "marketGrowth": 1.66,
    "marketShare": 34.44,
    "mmsGpDollars": 2745692,
    "mmsGpMargin": 3.1,
    "mmsGrowth": -8.45,
    "revenue": 11998,
    "mbGpDollars": 4611,
    "mbGpMargin": 38.43,
    "mbGrowth": 39.19,
    "mbOutpaceMms": 47.64,
    "mmsOutpaceMarket": -10.13,
    "mbVsMmsGp": 35.32,
    "nbSales": 88432981,
    "summary": {
      "headline": "Zero MB sales in high-growth category with strong margin potential.",
      "pros": [
        "39.2% MB growth rate significantly outpaces NB growth",
        "38.4% gross profit margin vastly exceeds NB at 3.1%",
        "Large $241.3M market with only 0.1% MB coverage"
      ],
      "cons": [
        "Currently zero McKesson Brands sales in category",
        "Minimal market coverage despite strong MMS position",
        "Must build distribution and brand presence from scratch"
      ]
    }
  },
  {
    "id": 10,
    "category": "Defibrillators",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 134446804,
    "marketGrowth": 9.92,
    "marketShare": 13.49,
    "mmsGpDollars": 6217335,
    "mmsGpMargin": 25.27,
    "mmsGrowth": 2.17,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": -7.66,
    "mbVsMmsGp": null,
    "nbSales": 24606783,
    "summary": {
      "headline": "Zero MB sales in growing market represents significant untapped opportunity.",
      "pros": [
        "Large $134.4M total market with 9.9% growth trajectory",
        "Strong NB gross profit margin of 25.3% indicates category viability",
        "Untapped Potential quadrant suggests room for MB market entry"
      ],
      "cons": [
        "Zero MB sales and penetration indicate competitive disadvantage currently",
        "MMS holds 13.5% share; establishing MB presence will be challenging",
        "Regulatory complexity and established competitors may limit rapid MB growth"
      ]
    }
  },
  {
    "id": 11,
    "category": "Diagnostic Cardiology",
    "tier": null,
    "penetration": 20.24,
    "coverage": 4.21,
    "totalMarket": 152690280,
    "marketGrowth": 12.69,
    "marketShare": 10.46,
    "mmsGpDollars": 2314342,
    "mmsGpMargin": 12.55,
    "mmsGrowth": -4.73,
    "revenue": 4679742,
    "mbGpDollars": 1005374,
    "mbGpMargin": 21.48,
    "mbGrowth": -6.88,
    "mbOutpaceMms": -2.16,
    "mmsOutpaceMarket": -13.09,
    "mbVsMmsGp": 8.93,
    "nbSales": 18436214,
    "summary": {
      "headline": "Tier 2: High-margin niche with significant untapped growth potential despite current headwinds.",
      "pros": [
        "Strong 21.5% gross profit margin versus 12.6% NB",
        "Large addressable market at $152.7M with 12.7% growth",
        "Untapped potential quadrant indicates expansion opportunities"
      ],
      "cons": [
        "MB sales declining -6.9% while market grows 12.7%",
        "Low penetration at 20% and coverage at 4.2%",
        "Underperforming NB by -2.2% in growth dynamics"
      ]
    }
  },
  {
    "id": 12,
    "category": "Diagnostic Disposables",
    "tier": null,
    "penetration": 31.77,
    "coverage": 2.82,
    "totalMarket": 926096512,
    "marketGrowth": 3.93,
    "marketShare": 12.74,
    "mmsGpDollars": 27950123,
    "mmsGpMargin": 30.53,
    "mmsGrowth": 0.72,
    "revenue": 42638420,
    "mbGpDollars": 19088886,
    "mbGpMargin": 44.77,
    "mbGrowth": 2.02,
    "mbOutpaceMms": 1.3,
    "mmsOutpaceMarket": -1.78,
    "mbVsMmsGp": 14.24,
    "nbSales": 91562712,
    "summary": {
      "headline": "Tier 2: Strong margin performer with selective growth but limited market penetration.",
      "pros": [
        "Superior GP% advantage of 14.3 points vs NB",
        "MB outpacing NB growth by 1.3 percentage points",
        "McKesson Brands Champions status confirms competitive strength",
        "Solid $42.6M sales base with healthy margins"
      ],
      "cons": [
        "Low market penetration at 32% limits growth potential",
        "Minimal coverage at 2.8% indicates narrow customer reach",
        "MB growth of 2.0% below market growth of 3.9%",
        "Selective Winner status suggests niche positioning constraints"
      ]
    }
  },
  {
    "id": 13,
    "category": "Diagnostic Imaging",
    "tier": null,
    "penetration": 15.09,
    "coverage": 2.54,
    "totalMarket": 99482785,
    "marketGrowth": 10.69,
    "marketShare": 13.58,
    "mmsGpDollars": 2557261,
    "mmsGpMargin": 16.29,
    "mmsGrowth": -2.29,
    "revenue": 2788715,
    "mbGpDollars": 686566,
    "mbGpMargin": 24.62,
    "mbGrowth": 4.53,
    "mbOutpaceMms": 6.82,
    "mmsOutpaceMarket": -15.71,
    "mbVsMmsGp": 8.33,
    "nbSales": 15696484,
    "summary": {
      "headline": "High-margin MB champion with significant untapped market expansion opportunity.",
      "pros": [
        "Strong 24.6% MB gross profit margin vs 16.3% NB",
        "MB outpacing NB growth by 6.8 percentage points",
        "Only 15% penetration indicates substantial growth runway",
        "Growing market at 10.7% provides tailwinds"
      ],
      "cons": [
        "Low 2.5% coverage limits current revenue potential",
        "Modest $2.8M MB sales despite market size",
        "4.5% MB growth lags overall market momentum",
        "MMS market share at 13.6% suggests competitive gaps"
      ]
    }
  },
  {
    "id": 14,
    "category": "Disposable Underwear",
    "tier": null,
    "penetration": 24.63,
    "coverage": 5.83,
    "totalMarket": 685922937,
    "marketGrowth": 5.24,
    "marketShare": 25.13,
    "mmsGpDollars": 26215325,
    "mmsGpMargin": 17.06,
    "mmsGrowth": 1.11,
    "revenue": 50219770,
    "mbGpDollars": 12821183,
    "mbGpMargin": 25.53,
    "mbGrowth": 6.48,
    "mbOutpaceMms": 5.37,
    "mmsOutpaceMarket": -6.1,
    "mbVsMmsGp": 8.47,
    "nbSales": 153679586,
    "summary": {
      "headline": "Tier 2: Strong growth leader with significant untapped market potential.",
      "pros": [
        "MB outpacing NB growth by 5.4 percentage points",
        "Superior gross profit margin: 25.5% vs NB 17.1%",
        "MB growth of 6.5% exceeds market growth of 5.2%"
      ],
      "cons": [
        "Low penetration at 25% indicates limited customer base",
        "Minimal coverage of 5.8% suggests distribution gaps",
        "Large market share available: MMS 25.1% of $685.9M market"
      ]
    }
  },
  {
    "id": 15,
    "category": "Distribution Fees",
    "tier": null,
    "penetration": -0.01,
    "coverage": 0.6,
    "totalMarket": 3514,
    "marketGrowth": 95.8,
    "marketShare": 80.44,
    "mmsGpDollars": 219290604,
    "mmsGpMargin": 98.8,
    "mmsGrowth": -15.85,
    "revenue": -11516,
    "mbGpDollars": -11516,
    "mbGpMargin": 100,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": -7.66,
    "mbVsMmsGp": 1.2,
    "nbSales": 221944870,
    "summary": {
      "headline": "Tier 5: No McKesson Brands sales in this category currently.",
      "pros": [
        "Massive market growth opportunity at 95.8% YoY",
        "McKesson strong 80.4% market share position",
        "Healthy NB gross margin of 98.8%"
      ],
      "cons": [
        "Zero MB sales revenue generation to date",
        "Minimal coverage at 0.6% despite market size",
        "Untapped potential requires significant investment"
      ]
    }
  },
  {
    "id": 16,
    "category": "Durable Medical Equipment",
    "tier": null,
    "penetration": 59,
    "coverage": 3.79,
    "totalMarket": 455742891,
    "marketGrowth": 6.09,
    "marketShare": 6.29,
    "mmsGpDollars": 3944261,
    "mmsGpMargin": 27.48,
    "mmsGrowth": -1.55,
    "revenue": 20650127,
    "mbGpDollars": 6838782,
    "mbGpMargin": 33.12,
    "mbGrowth": -8.25,
    "mbOutpaceMms": -6.7,
    "mmsOutpaceMarket": -6.21,
    "mbVsMmsGp": 5.64,
    "nbSales": 14352656,
    "summary": {
      "headline": "Tier 2: Established category with margin strength but declining momentum.",
      "pros": [
        "Strong gross profit margin at 33.1% versus NB 27.5%",
        "High penetration at 59% shows strong customer engagement",
        "Sizable $20.7M sales base provides revenue foundation"
      ],
      "cons": [
        "Negative 8.3% MB growth trend is concerning",
        "Underperforming NB by 6.7 points indicates competitive pressure",
        "Low 3.8% coverage limits expansion opportunity potential"
      ]
    }
  },
  {
    "id": 17,
    "category": "Electronic Health",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 616654,
    "marketGrowth": 1.71,
    "marketShare": 0,
    "mmsGpDollars": 17378,
    "mmsGpMargin": 23.62,
    "mmsGrowth": null,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": null,
    "mbVsMmsGp": null,
    "nbSales": 73576,
    "summary": {
      "headline": "No McKesson brand presence in modest, slow-growing market segment.",
      "pros": [
        "Untapped market opportunity with zero current penetration",
        "Positive market growth trajectory at 1.7% annually",
        "Strong NB gross profit margin of 23.6% demonstrates viability"
      ],
      "cons": [
        "Extremely small total market size of only $0.6M",
        "Zero McKesson sales and market share currently",
        "Low market growth insufficient to justify major investment priority"
      ]
    }
  },
  {
    "id": 18,
    "category": "Electronic Wearables",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 24801838,
    "marketGrowth": 12.32,
    "marketShare": 9.22,
    "mmsGpDollars": 716872,
    "mmsGpMargin": 21.72,
    "mmsGrowth": 486,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": 469.09,
    "mbVsMmsGp": null,
    "nbSales": 3299938,
    "summary": {
      "headline": "Tier 5: No McKesson Brands sales despite strong market opportunity.",
      "pros": [
        "Large addressable market at $24.8M with healthy 12.3% growth",
        "Strong non-brand gross margin at 21.7% indicates category profitability",
        "MMS holds 9.2% market share showing competitive positioning exists"
      ],
      "cons": [
        "Zero MB sales and penetration indicates complete category absence",
        "Untapped potential requires significant investment to build presence",
        "No MB growth data limits ability to assess future opportunity"
      ]
    }
  },
  {
    "id": 19,
    "category": "Exam & Patient Room Furnishing",
    "tier": null,
    "penetration": 7.43,
    "coverage": 1.08,
    "totalMarket": 377750083,
    "marketGrowth": 11.15,
    "marketShare": 11.3,
    "mmsGpDollars": 9608886,
    "mmsGpMargin": 17.55,
    "mmsGrowth": 3.82,
    "revenue": 4396176,
    "mbGpDollars": 1380020,
    "mbGpMargin": 31.39,
    "mbGrowth": -12.28,
    "mbOutpaceMms": -16.1,
    "mmsOutpaceMarket": -9.14,
    "mbVsMmsGp": 13.84,
    "nbSales": 54745106,
    "summary": {
      "headline": "Strong margins offset declining sales in underpenetrated market opportunity.",
      "pros": [
        "High gross profit margin of 31.4% versus NB 17.6%",
        "Massive market size at $377.8M with 11.2% growth",
        "Low penetration (7%) and coverage (1.1%) indicate expansion room"
      ],
      "cons": [
        "MB sales declining sharply at -12.3% year-over-year",
        "Underperforming non-brand by 16.1 percentage points",
        "Low coverage suggests weak customer adoption and relationships"
      ]
    }
  },
  {
    "id": 20,
    "category": "Exam Tables",
    "tier": null,
    "penetration": 1.2,
    "coverage": 3.2,
    "totalMarket": 256045230,
    "marketGrowth": 8.81,
    "marketShare": 23.42,
    "mmsGpDollars": 8170039,
    "mmsGpMargin": 10.65,
    "mmsGrowth": 1.08,
    "revenue": 930884,
    "mbGpDollars": 241962,
    "mbGpMargin": 25.99,
    "mbGrowth": -5.61,
    "mbOutpaceMms": -6.7,
    "mmsOutpaceMarket": -7.91,
    "mbVsMmsGp": 15.35,
    "nbSales": 76732949,
    "summary": {
      "headline": "Tier 2: High-margin niche with significant untapped growth potential despite current decline.",
      "pros": [
        "Strong 26% gross profit margin vs 10.7% NB",
        "Large $256M market with 8.8% growth trajectory",
        "Only 1% penetration indicates substantial expansion room"
      ],
      "cons": [
        "MB sales declining -5.6% while market grows 8.8%",
        "Underperforming NB by -6.7% in growth dynamics",
        "Low 3.2% coverage limits revenue scaling opportunity"
      ]
    }
  },
  {
    "id": 21,
    "category": "Feeding Supplies",
    "tier": null,
    "penetration": 3.05,
    "coverage": 2.07,
    "totalMarket": 453955103,
    "marketGrowth": 10.65,
    "marketShare": 31.74,
    "mmsGpDollars": 33600528,
    "mmsGpMargin": 14,
    "mmsGrowth": 9.66,
    "revenue": 7550031,
    "mbGpDollars": 2672772,
    "mbGpMargin": 35.4,
    "mbGrowth": 21.28,
    "mbOutpaceMms": 11.61,
    "mmsOutpaceMarket": 1.13,
    "mbVsMmsGp": 21.4,
    "nbSales": 240020627,
    "summary": {
      "headline": "Tier 2: High-growth MB brand with significant untapped market expansion opportunity.",
      "pros": [
        "Exceptional MB growth at 21.3% versus market 10.7%",
        "Strong gross profit margin advantage: 35.4% vs NB 14.0%",
        "Strategy Star positioning with favorable NB growth dynamics"
      ],
      "cons": [
        "Very low penetration at 3% indicates limited customer reach",
        "Minimal coverage at 2.1% suggests distribution gaps exist",
        "Untapped Potential quadrant means growth ceiling may be capped"
      ]
    }
  },
  {
    "id": 22,
    "category": "Flu",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 368126850,
    "marketGrowth": -2.76,
    "marketShare": 55.8,
    "mmsGpDollars": -3719708,
    "mmsGpMargin": -1.96,
    "mmsGrowth": 0.69,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": 3.61,
    "mbVsMmsGp": null,
    "nbSales": 189420990,
    "summary": {
      "headline": "Zero MB sales in large market represents significant untapped opportunity.",
      "pros": [
        "Large $368.1M market with strong MMS presence",
        "Untapped potential quadrant suggests growth runway",
        "Established market with 55.8% MMS market share"
      ],
      "cons": [
        "Negative market growth of -2.8% headwind",
        "Zero MB penetration and coverage currently",
        "Negative NB GP% indicates category margin pressure"
      ]
    }
  },
  {
    "id": 23,
    "category": "Food Service Disposables",
    "tier": null,
    "penetration": 66.78,
    "coverage": 8.49,
    "totalMarket": 121122987,
    "marketGrowth": 10.23,
    "marketShare": 24.44,
    "mmsGpDollars": 5369771,
    "mmsGpMargin": 40.53,
    "mmsGrowth": -0.87,
    "revenue": 26633624,
    "mbGpDollars": 9024230,
    "mbGpMargin": 33.88,
    "mbGrowth": 10.59,
    "mbOutpaceMms": 11.46,
    "mmsOutpaceMarket": -7.93,
    "mbVsMmsGp": -6.64,
    "nbSales": 13250095,
    "summary": {
      "headline": "Tier 1: Strong performer with market leadership and superior brand growth.",
      "pros": [
        "McKesson Brands significantly outpacing national brands growth",
        "High penetration at 67% shows strong customer adoption",
        "Market share leadership at 24.4% with healthy 10.2% growth"
      ],
      "cons": [
        "Gross profit margin trails national brands by 6.6 points",
        "Low coverage at 8.5% limits expansion opportunities",
        "Significant gap between penetration and coverage suggests untapped potential"
      ]
    }
  },
  {
    "id": 24,
    "category": "Food Supplements",
    "tier": null,
    "penetration": 0,
    "coverage": 0.32,
    "totalMarket": 1332145608,
    "marketGrowth": 7.23,
    "marketShare": 44.72,
    "mmsGpDollars": 105383062,
    "mmsGpMargin": 12.31,
    "mmsGrowth": 9.71,
    "revenue": 41963,
    "mbGpDollars": 9266,
    "mbGpMargin": 22.08,
    "mbGrowth": -31.77,
    "mbOutpaceMms": -41.49,
    "mmsOutpaceMarket": 2.21,
    "mbVsMmsGp": 9.77,
    "nbSales": 856368731,
    "summary": {
      "headline": "Tier 5: Zero MB sales despite significant market opportunity.",
      "pros": [
        "Large market size at $1.3B with healthy 7.2% growth",
        "Strong MMS market presence with 44.7% share indicates capability",
        "High MB gross margin potential at 22.1% if launched"
      ],
      "cons": [
        "Complete market absence: $0M MB sales, 0% penetration",
        "MB underperforming NB by -41.5% points historically",
        "Minimal store coverage at 0.3% limits category visibility"
      ]
    }
  },
  {
    "id": 25,
    "category": "Gauze",
    "tier": null,
    "penetration": 75.82,
    "coverage": 11.87,
    "totalMarket": 319984147,
    "marketGrowth": 4.55,
    "marketShare": 19.18,
    "mmsGpDollars": 5534858,
    "mmsGpMargin": 31.61,
    "mmsGrowth": -2.16,
    "revenue": 54899093,
    "mbGpDollars": 25356338,
    "mbGpMargin": 46.19,
    "mbGrowth": 5.11,
    "mbOutpaceMms": 7.27,
    "mmsOutpaceMarket": -3.33,
    "mbVsMmsGp": 14.58,
    "nbSales": 17512210,
    "summary": {
      "headline": "Strong MB performer with market leadership but limited growth headroom.",
      "pros": [
        "Leading MB growth outpacing NB by 7.3 percentage points",
        "High penetration at 76% shows strong customer adoption",
        "Superior GP margin of 46.2% vs NB at 31.6%"
      ],
      "cons": [
        "Low coverage at 11.9% indicates limited SKU breadth",
        "Modest market growth of 4.5% constrains expansion potential",
        "High penetration suggests limited new customer acquisition room"
      ]
    }
  },
  {
    "id": 26,
    "category": "Gloves",
    "tier": null,
    "penetration": 84.99,
    "coverage": 9.4,
    "totalMarket": 5015487487,
    "marketGrowth": -16.75,
    "marketShare": 11.2,
    "mmsGpDollars": 11937337,
    "mmsGpMargin": 24.05,
    "mmsGrowth": -6.71,
    "revenue": 281005945,
    "mbGpDollars": 101791451,
    "mbGpMargin": 36.22,
    "mbGrowth": -24.41,
    "mbOutpaceMms": -17.7,
    "mmsOutpaceMarket": 5.7,
    "mbVsMmsGp": 12.17,
    "nbSales": 49631647,
    "summary": {
      "headline": "Strong cash generator facing market headwinds; maintain but monitor decline.",
      "pros": [
        "Dominant market position with $281M sales and 85% penetration",
        "Superior margin advantage: 36.2% MB vs 24.1% NB gross profit",
        "Established category leadership despite challenging market conditions"
      ],
      "cons": [
        "Steep -24.4% MB sales decline outpacing market deterioration",
        "Low 9.4% coverage limits growth despite high penetration",
        "Opportunity Gap signals NB growing faster; losing competitive ground"
      ]
    }
  },
  {
    "id": 27,
    "category": "Hand Hygiene",
    "tier": null,
    "penetration": 44.55,
    "coverage": 6.27,
    "totalMarket": 330264643,
    "marketGrowth": 4.53,
    "marketShare": 9.44,
    "mmsGpDollars": 5467068,
    "mmsGpMargin": 27.02,
    "mmsGrowth": -4.27,
    "revenue": 16257535,
    "mbGpDollars": 6753192,
    "mbGpMargin": 41.54,
    "mbGrowth": 8.26,
    "mbOutpaceMms": 12.53,
    "mmsOutpaceMarket": -7.7,
    "mbVsMmsGp": 14.52,
    "nbSales": 20234647,
    "summary": {
      "headline": "Strong MB growth and margins justify Tier 1 priority positioning.",
      "pros": [
        "MB growing 8.3% annually, outpacing NB by 12.5 points",
        "Superior 41.5% GP% versus NB 27.0% demonstrates profitability",
        "Assortment Leader with McKesson Champions status signals market strength"
      ],
      "cons": [
        "Low 6.3% coverage limits market penetration opportunity upside",
        "45% penetration leaves 55% customer adoption gap remaining",
        "MMS 9.4% share indicates significant competitive market presence"
      ]
    }
  },
  {
    "id": 28,
    "category": "Home Environments",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 902537,
    "marketGrowth": 21.04,
    "marketShare": 8.41,
    "mmsGpDollars": 36358,
    "mmsGpMargin": 26.95,
    "mmsGrowth": -26.91,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": -47.98,
    "mbVsMmsGp": null,
    "nbSales": 134933,
    "summary": {
      "headline": "Tier 5: Zero MB sales despite strong market growth opportunity.",
      "pros": [
        "Strong market growth at 21.0% indicates category momentum",
        "Untapped potential with 0% penetration and no MB presence",
        "Healthy NB gross profit margin of 26.9%"
      ],
      "cons": [
        "No McKesson Brands sales or market presence currently",
        "Small total market size of $0.9M limits opportunity scale",
        "Competitors established with 8.4% MMS market share"
      ]
    }
  },
  {
    "id": 29,
    "category": "Housekeeping",
    "tier": null,
    "penetration": 33.06,
    "coverage": 3.78,
    "totalMarket": 544703093,
    "marketGrowth": 11.63,
    "marketShare": 10.52,
    "mmsGpDollars": 14480318,
    "mmsGpMargin": 26.54,
    "mmsGrowth": 1,
    "revenue": 26950672,
    "mbGpDollars": 10321427,
    "mbGpMargin": 38.3,
    "mbGrowth": 10.06,
    "mbOutpaceMms": 9.06,
    "mmsOutpaceMarket": -8.06,
    "mbVsMmsGp": 11.76,
    "nbSales": 54564253,
    "summary": {
      "headline": "Strong MB growth and margins warrant Tier 2 investment despite selective market penetration.",
      "pros": [
        "MB outpacing NB by 9.1% with 10.1% growth rate",
        "Excellent GP% advantage: 38.3% MB vs 26.5% NB",
        "McKesson Brands Champions status signals strong competitive position"
      ],
      "cons": [
        "Low penetration at 33% limits growth ceiling significantly",
        "Minimal coverage at 3.8% indicates sparse customer reach",
        "Large market gap: $27M MB vs $544.7M total market"
      ]
    }
  },
  {
    "id": 30,
    "category": "Inco Wipes",
    "tier": null,
    "penetration": 63.44,
    "coverage": 14.5,
    "totalMarket": 377363353,
    "marketGrowth": 4.96,
    "marketShare": 17.76,
    "mmsGpDollars": 5533026,
    "mmsGpMargin": 19.29,
    "mmsGrowth": 1.17,
    "revenue": 49751361,
    "mbGpDollars": 18926591,
    "mbGpMargin": 38.04,
    "mbGrowth": 9.95,
    "mbOutpaceMms": 8.79,
    "mmsOutpaceMarket": -4.92,
    "mbVsMmsGp": 18.75,
    "nbSales": 28677509,
    "summary": {
      "headline": "Strong MB growth and margins justify Tier 1 priority despite coverage gaps.",
      "pros": [
        "MB growing 9.9% vs NB growth, significantly outpacing competition",
        "38.0% GP% nearly double NB's 19.3%, high profitability",
        "63% penetration shows strong customer adoption and loyalty"
      ],
      "cons": [
        "14.5% coverage severely limits growth potential and revenue expansion",
        "17.8% MMS market share leaves substantial competitive vulnerability",
        "High penetration with low coverage suggests untapped customer base"
      ]
    }
  },
  {
    "id": 31,
    "category": "Incontinence Briefs",
    "tier": null,
    "penetration": 23.84,
    "coverage": 5.85,
    "totalMarket": 755018121,
    "marketGrowth": 6.72,
    "marketShare": 30.19,
    "mmsGpDollars": 33793212,
    "mmsGpMargin": 15.87,
    "mmsGrowth": 4.46,
    "revenue": 66676785,
    "mbGpDollars": 15603679,
    "mbGpMargin": 23.4,
    "mbGrowth": 10.53,
    "mbOutpaceMms": 6.07,
    "mmsOutpaceMarket": -2.27,
    "mbVsMmsGp": 7.53,
    "nbSales": 212949153,
    "summary": {
      "headline": "Strong growth momentum and margin advantage warrant Tier 1 investment priority.",
      "pros": [
        "MB outpacing NB growth by 6.1 percentage points significantly",
        "23.4% gross profit margin substantially exceeds NB at 15.9%",
        "10.5% MB growth in 6.7% total market demonstrates momentum"
      ],
      "cons": [
        "24% penetration leaves 76% untapped market opportunity",
        "5.8% coverage severely limits market reach and scale",
        "30.2% MMS share suggests strong competitor presence limiting gains"
      ]
    }
  },
  {
    "id": 32,
    "category": "IV Therapy",
    "tier": null,
    "penetration": 8.84,
    "coverage": 3.33,
    "totalMarket": 5171089961,
    "marketGrowth": 6.39,
    "marketShare": 8.77,
    "mmsGpDollars": 156928231,
    "mmsGpMargin": 23.27,
    "mmsGrowth": 1.06,
    "revenue": 65361648,
    "mbGpDollars": 25018388,
    "mbGpMargin": 38.28,
    "mbGrowth": 16.43,
    "mbOutpaceMms": 15.37,
    "mmsOutpaceMarket": -2.22,
    "mbVsMmsGp": 15,
    "nbSales": 674316258,
    "summary": {
      "headline": "Tier 2: High-growth MB champion with significant untapped market expansion opportunity.",
      "pros": [
        "Strong MB growth at 16.4%, significantly outpacing NB growth",
        "Excellent gross profit margin of 38.3% demonstrates pricing power",
        "Untapped potential with only 9% penetration and 3.3% coverage",
        "Large addressable market of $5.1B with healthy 6.4% growth"
      ],
      "cons": [
        "Low market penetration at 9% indicates competitive or execution gaps",
        "Minimal coverage at 3.3% limits revenue scaling opportunities",
        "MMS market share of 8.8% lags total market size significantly",
        "Heavy reliance on continued MB growth sustainability over time"
      ]
    }
  },
  {
    "id": 33,
    "category": "Kits, Custom & Standard",
    "tier": null,
    "penetration": 16.1,
    "coverage": 1.2,
    "totalMarket": 3655514104,
    "marketGrowth": 7.77,
    "marketShare": 2.41,
    "mmsGpDollars": 18463566,
    "mmsGpMargin": 17.61,
    "mmsGrowth": -0.6,
    "revenue": 20123073,
    "mbGpDollars": 7847823,
    "mbGpMargin": 39,
    "mbGrowth": -2.74,
    "mbOutpaceMms": -2.15,
    "mmsOutpaceMarket": -1.25,
    "mbVsMmsGp": 21.39,
    "nbSales": 104850014,
    "summary": {
      "headline": "Strong margins with growth headwinds warrant monitored investment.",
      "pros": [
        "High GP% of 39.0% significantly outpaces NB at 17.6%",
        "Large market of $3.6B presents substantial expansion opportunity",
        "Low coverage at 1.2% indicates untapped account potential"
      ],
      "cons": [
        "Negative MB growth of -2.7% trending away from market",
        "Underperforming NB by 2.1% suggests competitive weakness",
        "Low penetration at 16% with declining sales trajectory"
      ]
    }
  },
  {
    "id": 34,
    "category": "Lab - Cardiac Marker",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 100993447,
    "marketGrowth": -14.32,
    "marketShare": 33.86,
    "mmsGpDollars": 3203421,
    "mmsGpMargin": 22.33,
    "mmsGrowth": -4.58,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": 12.78,
    "mbVsMmsGp": null,
    "nbSales": 14342921,
    "summary": {
      "headline": "Tier 5: No McKesson Brands sales in declining market.",
      "pros": [
        "Large total market opportunity at $101.0M",
        "Strong competitor presence shows market viability",
        "Category exists with measurable demand"
      ],
      "cons": [
        "Zero McKesson Brands sales and penetration",
        "Market declining at -14.3% annually",
        "Competitor (MMS) dominates with 33.9% share",
        "No growth trajectory to build from",
        "Negative market dynamics reduce entry attractiveness"
      ]
    }
  },
  {
    "id": 35,
    "category": "Lab - POC Chemistry",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 38208921,
    "marketGrowth": 7.54,
    "marketShare": 45.54,
    "mmsGpDollars": 4256519,
    "mmsGpMargin": 18.87,
    "mmsGrowth": 10.52,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": 3.28,
    "mbVsMmsGp": null,
    "nbSales": 22553695,
    "summary": {
      "headline": "Zero MB presence in growing market with strong MMS position.",
      "pros": [
        "Large $38.2M market with healthy 7.5% growth trajectory",
        "MMS commands 45.5% market share, demonstrating category strength",
        "Untapped potential indicates significant opportunity for MB entry"
      ],
      "cons": [
        "Complete absence of MB sales and brand presence currently",
        "NB competitors established with 18.9% gross profit margins",
        "Zero penetration and coverage require substantial investment to compete"
      ]
    }
  },
  {
    "id": 36,
    "category": "Lab-Allergy",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 66189636,
    "marketGrowth": 19.46,
    "marketShare": 0.45,
    "mmsGpDollars": 132871,
    "mmsGpMargin": 25.89,
    "mmsGrowth": 13.23,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": -6.14,
    "mbVsMmsGp": null,
    "nbSales": 513178,
    "summary": {
      "headline": "Tier 5: Zero MB sales in high-growth market opportunity",
      "pros": [
        "Large market size at $66.2M with strong 19.5% growth",
        "Untapped potential quadrant suggests significant expansion opportunity",
        "Competitive NB gross profit of 25.9% shows category viability"
      ],
      "cons": [
        "No McKesson Brands sales or penetration in category",
        "Low MMS market share at 0.5% indicates weak positioning",
        "Requires substantial investment to enter and compete effectively"
      ]
    }
  },
  {
    "id": 37,
    "category": "Lab-Blood Bank",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 73032083,
    "marketGrowth": 3.94,
    "marketShare": 4.83,
    "mmsGpDollars": 961199,
    "mmsGpMargin": 24.22,
    "mmsGrowth": 0.92,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": -2.65,
    "mbVsMmsGp": null,
    "nbSales": 3967878,
    "summary": {
      "headline": "Zero MB presence in growing market represents significant untapped opportunity.",
      "pros": [
        "Large $73M market with healthy 3.9% growth trajectory",
        "Untapped potential quadrant offers greenfield expansion opportunity",
        "Competitor NB showing 24.2% gross margin demonstrates category profitability"
      ],
      "cons": [
        "Complete market absence requires substantial infrastructure investment",
        "MMS only 4.8% share suggests entrenched competitive dynamics",
        "No historical MB data limits growth trajectory predictability"
      ]
    }
  },
  {
    "id": 38,
    "category": "Lab-Blood Glucose Meters & Sup",
    "tier": null,
    "penetration": 28.8,
    "coverage": 6.85,
    "totalMarket": 462285294,
    "marketGrowth": 10.87,
    "marketShare": 14.14,
    "mmsGpDollars": 9706227,
    "mmsGpMargin": 14.97,
    "mmsGrowth": 13.09,
    "revenue": 26232037,
    "mbGpDollars": 10427320,
    "mbGpMargin": 39.75,
    "mbGrowth": 7.95,
    "mbOutpaceMms": -5.14,
    "mmsOutpaceMarket": 2.29,
    "mbVsMmsGp": 24.78,
    "nbSales": 64851621,
    "summary": {
      "headline": "Strong margins and market position offset by lagging growth and low coverage.",
      "pros": [
        "Market-leading 39.8% gross profit margin vs NB 15%",
        "Assortment leader with strong brand penetration at 29%",
        "Solid $26.2M sales base in growing 10.9% market"
      ],
      "cons": [
        "MB growth 5.1pp below NB; losing competitive momentum",
        "Coverage critically low at 6.8%; untapped distribution opportunity",
        "Underperforming market share despite category growth tailwinds"
      ]
    }
  },
  {
    "id": 39,
    "category": "Lab-Chemistry",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 614384310,
    "marketGrowth": 1.57,
    "marketShare": 25.52,
    "mmsGpDollars": 39901286,
    "mmsGpMargin": 23.99,
    "mmsGrowth": 4.2,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": 2.61,
    "mbVsMmsGp": null,
    "nbSales": 166311267,
    "summary": {
      "headline": "Tier 5: No McKesson Brands sales in large, stable market.",
      "pros": [
        "Large $614.4M market with established demand",
        "Healthy 24% NB gross profit margin",
        "MMS has strong 25.5% market share position"
      ],
      "cons": [
        "Zero MB sales and zero penetration currently",
        "No MB growth trajectory or competitive metrics",
        "Requires significant investment to build presence"
      ]
    }
  },
  {
    "id": 40,
    "category": "Lab-Coagulation",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 13608217,
    "marketGrowth": 1.81,
    "marketShare": 34.29,
    "mmsGpDollars": 1067682,
    "mmsGpMargin": 21.4,
    "mmsGrowth": -3.5,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": -5.66,
    "mbVsMmsGp": null,
    "nbSales": 4989906,
    "summary": {
      "headline": "Zero MB presence in growing market represents significant untapped opportunity.",
      "pros": [
        "Large $13.6M total market with steady 1.8% growth",
        "MMS holds strong 34.3% market share demonstrating category strength",
        "Untapped Potential quadrant signals greenfield expansion opportunity"
      ],
      "cons": [
        "Complete absence of MB sales indicates no established infrastructure",
        "NB competitor maintains healthy 21.4% gross profit margins",
        "Building from zero requires significant market development investment"
      ]
    }
  },
  {
    "id": 41,
    "category": "Lab-General Lab Equipment",
    "tier": null,
    "penetration": 11.46,
    "coverage": 1.61,
    "totalMarket": 307812305,
    "marketGrowth": 2.44,
    "marketShare": 7.77,
    "mmsGpDollars": 5648533,
    "mmsGpMargin": 24.08,
    "mmsGrowth": -6.77,
    "revenue": 3035463,
    "mbGpDollars": 1046977,
    "mbGpMargin": 34.49,
    "mbGrowth": -1.9,
    "mbOutpaceMms": 4.87,
    "mmsOutpaceMarket": -8.57,
    "mbVsMmsGp": 10.41,
    "nbSales": 23457720,
    "summary": {
      "headline": "Strong margin leader with growth momentum despite low market penetration.",
      "pros": [
        "Superior GP% advantage: 34.5% vs NB 24.1%",
        "MB outpacing NB growth by 4.9 percentage points",
        "Large untapped market: 89% penetration opportunity",
        "Solid MMS market share at 7.8%"
      ],
      "cons": [
        "MB sales declining at -1.9% despite NB outperformance",
        "Very low coverage at 1.6% limits growth scaling",
        "Slowing market growth at 2.4% constrains expansion",
        "Low absolute penetration at 11% indicates customer underutilization"
      ]
    }
  },
  {
    "id": 42,
    "category": "Lab-Hematology",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 170565354,
    "marketGrowth": 1.37,
    "marketShare": 44.01,
    "mmsGpDollars": 17546419,
    "mmsGpMargin": 22.35,
    "mmsGrowth": -0.89,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": -2.16,
    "mbVsMmsGp": null,
    "nbSales": 78516191,
    "summary": {
      "headline": "Tier 5: No McKesson Brands sales in large, stable market.",
      "pros": [
        "Large market size at $170.6M with stable growth",
        "Strong MMS market share at 44% shows category strength",
        "Untapped potential with zero MB penetration opportunity"
      ],
      "cons": [
        "Zero MB sales and zero penetration indicate no current presence",
        "Cannot assess MB growth or competitive dynamics without sales data",
        "NB margin at 22.4% suggests profitability exists elsewhere"
      ]
    }
  },
  {
    "id": 43,
    "category": "Lab-Immunoassay",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 449301987,
    "marketGrowth": 2.36,
    "marketShare": 33.9,
    "mmsGpDollars": 38670403,
    "mmsGpMargin": 23.53,
    "mmsGrowth": 3.34,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": 1.56,
    "mbVsMmsGp": null,
    "nbSales": 164352908,
    "summary": {
      "headline": "Tier 5: No McKesson Brands sales in large immunoassay market.",
      "pros": [
        "Large market opportunity at $449.3M total addressable market",
        "Healthy market growth at 2.4% year-over-year",
        "Strong competitor presence shows viable market demand"
      ],
      "cons": [
        "Zero McKesson Brands revenue and no market penetration",
        "Competitor MMS holds 33.9% share; entry barriers exist",
        "Comparable NB gross profit 23.5% sets high performance bar"
      ]
    }
  },
  {
    "id": 44,
    "category": "Lab-Instrument Driven Testing",
    "tier": null,
    "penetration": 4.79,
    "coverage": 4.07,
    "totalMarket": 570867105,
    "marketGrowth": 4,
    "marketShare": 42.07,
    "mmsGpDollars": 65752196,
    "mmsGpMargin": 24.83,
    "mmsGrowth": 3.54,
    "revenue": 13315301,
    "mbGpDollars": 5459379,
    "mbGpMargin": 41,
    "mbGrowth": 4.51,
    "mbOutpaceMms": 0.97,
    "mmsOutpaceMarket": -0.42,
    "mbVsMmsGp": 16.17,
    "nbSales": 264831928,
    "summary": {
      "headline": "High-margin champion with massive untapped growth opportunity ahead.",
      "pros": [
        "Superior 41% gross profit margin versus 24.8% NB",
        "Strong MB outpacing NB growth by 1.0 percentage point",
        "Massive $557.6M untapped market opportunity remains"
      ],
      "cons": [
        "Very low 5% penetration limits current revenue scale",
        "Minimal 4.1% coverage means thin customer base",
        "Market growth at 4% may limit expansion pace"
      ]
    }
  },
  {
    "id": 45,
    "category": "Lab-Lab Services",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 11736381,
    "marketGrowth": -5.15,
    "marketShare": 4.88,
    "mmsGpDollars": 248630,
    "mmsGpMargin": 35.36,
    "mmsGrowth": -7.35,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": -5.21,
    "mbVsMmsGp": null,
    "nbSales": 703160,
    "summary": {
      "headline": "Tier 5: No McKesson Brands sales in declining market segment.",
      "pros": [
        "Untapped potential with $11.7M total market available",
        "Competitor MMS holds only 4.9% market share",
        "Non-brand gross profit of 35.4% shows category profitability"
      ],
      "cons": [
        "Market declining at -5.2% annually; headwinds ahead",
        "Zero MB penetration and coverage indicates no foothold",
        "Zero MB sales and GP% shows complete absence"
      ]
    }
  },
  {
    "id": 46,
    "category": "Lab-Lab Supplies",
    "tier": null,
    "penetration": 9.77,
    "coverage": 2.01,
    "totalMarket": 688108309,
    "marketGrowth": -2.68,
    "marketShare": 4.81,
    "mmsGpDollars": 12177252,
    "mmsGpMargin": 35.89,
    "mmsGrowth": 4.44,
    "revenue": 3673475,
    "mbGpDollars": 1639370,
    "mbGpMargin": 44.63,
    "mbGrowth": 2.5,
    "mbOutpaceMms": -1.94,
    "mmsOutpaceMarket": 8.76,
    "mbVsMmsGp": 8.74,
    "nbSales": 33933168,
    "summary": {
      "headline": "Tier 2: Strong margins with significant untapped growth potential despite market headwinds.",
      "pros": [
        "Superior GP% of 44.6% versus NB at 35.9%",
        "Low penetration (10%) indicates substantial expansion opportunity",
        "MB growing despite negative market conditions (-2.7%)"
      ],
      "cons": [
        "MB underperforming NB growth by 1.9 percentage points",
        "Declining market (-2.7%) limits category tailwinds",
        "Low coverage (2.0%) suggests limited customer reach"
      ]
    }
  },
  {
    "id": 47,
    "category": "Lab-LC/MS",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 14703454,
    "marketGrowth": 12.8,
    "marketShare": 19.38,
    "mmsGpDollars": 869957,
    "mmsGpMargin": 21.24,
    "mmsGrowth": 13.62,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": 1.16,
    "mbVsMmsGp": null,
    "nbSales": 4095586,
    "summary": {
      "headline": "Tier 5: No McKesson Brands sales despite $14.7M growing market.",
      "pros": [
        "Large market size at $14.7M with healthy 12.8% growth",
        "MMS holds 19.4% market share showing category viability",
        "Untapped potential with zero MB penetration and coverage"
      ],
      "cons": [
        "Zero MB sales and zero gross profit currently",
        "Complete market absence requires significant investment to enter",
        "NB competitors established with 21.2% GP margin advantage"
      ]
    }
  },
  {
    "id": 48,
    "category": "Lab-LIS",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 13089222,
    "marketGrowth": 1.64,
    "marketShare": 30.28,
    "mmsGpDollars": 784485,
    "mmsGpMargin": 18.81,
    "mmsGrowth": 1.99,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": 2.15,
    "mbVsMmsGp": null,
    "nbSales": 4171127,
    "summary": {
      "headline": "Tier 5: Zero McKesson Brands sales in growing market segment.",
      "pros": [
        "Large market opportunity at $13.1M total size",
        "Moderate market growth at 1.6% provides expansion runway",
        "MMS holds 30.3% share showing category viability"
      ],
      "cons": [
        "No McKesson Brands presence or sales currently",
        "Untapped potential requires significant market entry investment",
        "Competitive MMS position limits easy market penetration"
      ]
    }
  },
  {
    "id": 49,
    "category": "Lab-Microbiology",
    "tier": null,
    "penetration": 0.36,
    "coverage": 0.06,
    "totalMarket": 430687372,
    "marketGrowth": 0.72,
    "marketShare": 3.63,
    "mmsGpDollars": 4590722,
    "mmsGpMargin": 19.58,
    "mmsGrowth": 0.32,
    "revenue": 85392,
    "mbGpDollars": 34405,
    "mbGpMargin": 40.29,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": 0.59,
    "mbVsMmsGp": 20.71,
    "nbSales": 23440686,
    "summary": {
      "headline": "Tier 3: Minimal MB presence in large, slow-growth market.",
      "pros": [
        "Strong gross margin of 40.3% vs NB at 19.6%",
        "Large total addressable market of $430.7M",
        "Positioned in Untapped Potential quadrant for growth"
      ],
      "cons": [
        "Negligible MB sales of only $0.1M",
        "Zero penetration and 0.1% coverage indicate weak presence",
        "Slow market growth of 0.7% limits upside potential"
      ]
    }
  },
  {
    "id": 50,
    "category": "Lab-Molecular - NW",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 293751969,
    "marketGrowth": -24.02,
    "marketShare": 13.79,
    "mmsGpDollars": 5066807,
    "mmsGpMargin": 18.7,
    "mmsGrowth": -3.78,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": 22.06,
    "mbVsMmsGp": null,
    "nbSales": 27098769,
    "summary": {
      "headline": "Tier 5: Zero McKesson Brands sales in declining market segment.",
      "pros": [
        "Large total market size of $293.8M offers growth potential",
        "MMS maintains 13.8% market share despite category decline",
        "Competitor NB products show 18.7% gross margin opportunity"
      ],
      "cons": [
        "Market declining sharply at -24.0% year-over-year",
        "Zero McKesson Brands penetration and coverage in category",
        "No MB growth data or competitive positioning established"
      ]
    }
  },
  {
    "id": 51,
    "category": "Lab-Molecular - W",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 1517,
    "marketGrowth": 472.99,
    "marketShare": 59.23,
    "mmsGpDollars": 55160,
    "mmsGpMargin": 23.59,
    "mmsGrowth": null,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": null,
    "mbVsMmsGp": null,
    "nbSales": 233822,
    "summary": {
      "headline": "Tier 5: Zero MB sales with untapped market potential.",
      "pros": [
        "Explosive market growth at 473% demonstrates strong demand",
        "MMS holds 59.2% market share, establishing category credibility",
        "Untapped potential quadrant offers greenfield opportunity for entry"
      ],
      "cons": [
        "No McKesson Brand sales or presence in category",
        "Zero penetration and coverage indicate complete market absence",
        "High NB GP% suggests competitors capturing margin opportunity"
      ]
    }
  },
  {
    "id": 52,
    "category": "Lab-Pathology",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 37991086,
    "marketGrowth": 1.17,
    "marketShare": 1.49,
    "mmsGpDollars": 185963,
    "mmsGpMargin": 30.89,
    "mmsGrowth": -4.14,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": -0.24,
    "mbVsMmsGp": null,
    "nbSales": 601926,
    "summary": {
      "headline": "Tier 5: Zero MB sales in growing market with untapped potential.",
      "pros": [
        "Large $38M market with room for growth",
        "Stable market growth trajectory at 1.2%",
        "Untapped potential quadrant offers expansion opportunity"
      ],
      "cons": [
        "Zero MB sales and penetration indicates no market entry",
        "Low MMS market share at 1.5% suggests weak position",
        "NB competitors maintain healthy 30.9% gross profit margins"
      ]
    }
  },
  {
    "id": 53,
    "category": "Lab-Rapids",
    "tier": null,
    "penetration": 50.89,
    "coverage": 3.16,
    "totalMarket": 165103257,
    "marketGrowth": 8.05,
    "marketShare": 26.08,
    "mmsGpDollars": 8140296,
    "mmsGpMargin": 30.73,
    "mmsGrowth": 0.62,
    "revenue": 27448660,
    "mbGpDollars": 10509973,
    "mbGpMargin": 38.29,
    "mbGrowth": 7.15,
    "mbOutpaceMms": 6.53,
    "mmsOutpaceMarket": -6.81,
    "mbVsMmsGp": 7.56,
    "nbSales": 26488883,
    "summary": {
      "headline": "Tier 2: Strong MB performer with significant untapped coverage potential.",
      "pros": [
        "McKesson Brands outpacing NB growth by 650 basis points",
        "Superior GP margin: 38.3% MB vs 30.7% NB",
        "Selective Winner positioning with proven penetration at 51%"
      ],
      "cons": [
        "Coverage severely limited at only 3.2% of accounts",
        "MB growth at 7.2% below market growth of 8.1%",
        "Significant whitespace: 49% market penetration not yet captured"
      ]
    }
  },
  {
    "id": 54,
    "category": "Lab-Respiratory Testing",
    "tier": null,
    "penetration": 7.14,
    "coverage": 2.72,
    "totalMarket": 4990134873,
    "marketGrowth": -21.63,
    "marketShare": 38.37,
    "mmsGpDollars": 176670644,
    "mmsGpMargin": 19.6,
    "mmsGrowth": -22.78,
    "revenue": 69322603,
    "mbGpDollars": 22277830,
    "mbGpMargin": 32.14,
    "mbGrowth": 31.57,
    "mbOutpaceMms": 54.35,
    "mmsOutpaceMarket": -1.59,
    "mbVsMmsGp": 12.53,
    "nbSales": 901242714,
    "summary": {
      "headline": "Strong MB growth momentum despite market headwinds and low penetration.",
      "pros": [
        "31.6% MB growth significantly outpaces NB by 54.4%",
        "12.5% GP% advantage over NB at 32.1%",
        "38.4% MMS market share provides distribution strength"
      ],
      "cons": [
        "Only 7% penetration indicates massive untapped opportunity",
        "Declining market (-21.6%) limits category expansion potential",
        "2.7% coverage shows minimal customer reach despite $69.3M sales"
      ]
    }
  },
  {
    "id": 55,
    "category": "Lab-Specimen Collection",
    "tier": null,
    "penetration": 23.43,
    "coverage": 3.91,
    "totalMarket": 1173294018,
    "marketGrowth": 3.43,
    "marketShare": 10.5,
    "mmsGpDollars": 26837817,
    "mmsGpMargin": 25.38,
    "mmsGrowth": 0.44,
    "revenue": 32362913,
    "mbGpDollars": 14220533,
    "mbGpMargin": 43.94,
    "mbGrowth": 12.13,
    "mbOutpaceMms": 11.69,
    "mmsOutpaceMarket": -1.05,
    "mbVsMmsGp": 18.56,
    "nbSales": 105747833,
    "summary": {
      "headline": "Tier 1: High-growth MB champion with significant untapped market potential.",
      "pros": [
        "Strong MB growth at 12.1%, outpacing NB by 11.7%",
        "Excellent gross profit margin of 43.9% vs NB 25.4%",
        "Large addressable market of $1.17B with only 23% penetration"
      ],
      "cons": [
        "Very low coverage at 3.9% indicates distribution gaps",
        "MMS market share only 10.5% despite category strength",
        "Modest market growth of 3.4% limits category tailwinds"
      ]
    }
  },
  {
    "id": 56,
    "category": "Lab-Urinalysis",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 2023112,
    "marketGrowth": 14.21,
    "marketShare": 35.24,
    "mmsGpDollars": 122587,
    "mmsGpMargin": 17.03,
    "mmsGrowth": 26.75,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": 14.68,
    "mbVsMmsGp": null,
    "nbSales": 719831,
    "summary": {
      "headline": "Tier 5: Zero MB sales in growing $2M market with strong MMS presence.",
      "pros": [
        "Strong market growth at 14.2% year-over-year",
        "MMS commands 35.2% market share, demonstrating category viability",
        "Untapped potential with zero current MB penetration"
      ],
      "cons": [
        "No McKesson Brands sales or margin contribution currently",
        "Competitors already established with significant market share",
        "Zero penetration suggests weak market positioning or strategy"
      ]
    }
  },
  {
    "id": 57,
    "category": "N/A",
    "tier": null,
    "penetration": 0.01,
    "coverage": 8.33,
    "totalMarket": null,
    "marketGrowth": null,
    "marketShare": null,
    "mmsGpDollars": 1083078,
    "mmsGpMargin": 99.9,
    "mmsGrowth": -63.81,
    "revenue": 118,
    "mbGpDollars": 40,
    "mbGpMargin": 34.1,
    "mbGrowth": 21.6,
    "mbOutpaceMms": 85.41,
    "mmsOutpaceMarket": null,
    "mbVsMmsGp": -65.8,
    "nbSales": 1084541,
    "summary": {
      "headline": "Tier 5: No current MB sales; requires market validation and strategy.",
      "pros": [
        "Strong MB growth trajectory at 21.6% year-over-year",
        "MB significantly outpacing NB growth by 85.4 percentage points",
        "Healthy gross profit margin of 34.1% on MB sales"
      ],
      "cons": [
        "Zero MB sales revenue indicates no market traction yet",
        "Minimal coverage at 8.3% limits growth potential significantly",
        "Missing market size and share data prevents informed prioritization"
      ]
    }
  },
  {
    "id": 58,
    "category": "Needles & Syringes",
    "tier": null,
    "penetration": 25.16,
    "coverage": 4.34,
    "totalMarket": 896728219,
    "marketGrowth": 6.56,
    "marketShare": 21.16,
    "mmsGpDollars": 52765105,
    "mmsGpMargin": 29.16,
    "mmsGrowth": 9.1,
    "revenue": 60814738,
    "mbGpDollars": 25907338,
    "mbGpMargin": 42.6,
    "mbGrowth": -6.51,
    "mbOutpaceMms": -15.6,
    "mmsOutpaceMarket": 0.75,
    "mbVsMmsGp": 13.44,
    "nbSales": 180931697,
    "summary": {
      "headline": "Tier 2: Strong margin position undermined by declining sales and low market penetration.",
      "pros": [
        "Superior gross profit margin at 42.6% vs NB 29.2%",
        "Significant absolute sales of $60.8M in large market",
        "Market leader position with 21.2% MMS share"
      ],
      "cons": [
        "Declining MB sales at -6.5% year-over-year",
        "Severely underperforming NB growth by -15.6 points",
        "Low penetration at 25% indicates untapped account potential"
      ]
    }
  },
  {
    "id": 59,
    "category": "Office Supplies",
    "tier": null,
    "penetration": 6.14,
    "coverage": 0.09,
    "totalMarket": 76374839,
    "marketGrowth": 10.27,
    "marketShare": 0.05,
    "mmsGpDollars": 7472557,
    "mmsGpMargin": 33.61,
    "mmsGrowth": -16.53,
    "revenue": 1453973,
    "mbGpDollars": 602894,
    "mbGpMargin": 41.47,
    "mbGrowth": 10.11,
    "mbOutpaceMms": 26.63,
    "mmsOutpaceMarket": -7.82,
    "mbVsMmsGp": 7.85,
    "nbSales": 22230100,
    "summary": {
      "headline": "Tier 2: High-growth MB champion with significant untapped market expansion potential.",
      "pros": [
        "MB growing 26.6% faster than NB competitors",
        "Strong 41.5% gross profit margin versus NB 33.6%",
        "10.3% market growth provides favorable expansion tailwinds"
      ],
      "cons": [
        "Only 6% penetration indicates massive customer acquisition gap",
        "Minimal 0.1% coverage limits distribution reach and scale",
        "Low 0.1% MMS share shows weak competitive positioning overall"
      ]
    }
  },
  {
    "id": 60,
    "category": "Orthopedics",
    "tier": null,
    "penetration": 26.83,
    "coverage": 2.41,
    "totalMarket": 546398944,
    "marketGrowth": 3.02,
    "marketShare": 13.7,
    "mmsGpDollars": 16047872,
    "mmsGpMargin": 26.2,
    "mmsGrowth": -3.85,
    "revenue": 22469128,
    "mbGpDollars": 8922759,
    "mbGpMargin": 39.71,
    "mbGrowth": 7.51,
    "mbOutpaceMms": 11.36,
    "mmsOutpaceMarket": -6.34,
    "mbVsMmsGp": 13.52,
    "nbSales": 61262337,
    "summary": {
      "headline": "Strong MB momentum in underpenetrated market warrants Tier 2 priority.",
      "pros": [
        "MB outpacing NB growth by 11.4 percentage points significantly",
        "39.7% gross profit margin substantially exceeds NB at 26.2%",
        "7.5% MB growth in 3.0% market shows market share gains"
      ],
      "cons": [
        "27% penetration leaves significant untapped customer opportunity ahead",
        "2.4% coverage indicates selective distribution limiting revenue potential",
        "13.7% MMS market share suggests competitive intensity in category"
      ]
    }
  },
  {
    "id": 61,
    "category": "Ostomy",
    "tier": null,
    "penetration": 0.6,
    "coverage": 0.34,
    "totalMarket": 384262144,
    "marketGrowth": 3.5,
    "marketShare": 19.9,
    "mmsGpDollars": 11440406,
    "mmsGpMargin": 13.37,
    "mmsGrowth": -2.06,
    "revenue": 518848,
    "mbGpDollars": 183010,
    "mbGpMargin": 35.27,
    "mbGrowth": 3.8,
    "mbOutpaceMms": 5.86,
    "mmsOutpaceMarket": -5.55,
    "mbVsMmsGp": 21.9,
    "nbSales": 85577615,
    "summary": {
      "headline": "Tier 2: High-growth niche with massive untapped market potential.",
      "pros": [
        "MB outpacing NB growth by 5.9 percentage points significantly",
        "Strong gross profit margin of 35.3% versus NB 13.4%",
        "Untapped potential in large $384.3M market with low penetration"
      ],
      "cons": [
        "Very low penetration at 1% and coverage at 0.3%",
        "Small current sales base of $0.5M limits immediate revenue impact",
        "Low market growth rate of 3.5% constrains category expansion"
      ]
    }
  },
  {
    "id": 62,
    "category": "Patient Assessment/Monitoring",
    "tier": null,
    "penetration": 14.91,
    "coverage": 2.46,
    "totalMarket": 1851389588,
    "marketGrowth": 4.89,
    "marketShare": 8.52,
    "mmsGpDollars": 31782945,
    "mmsGpMargin": 20.07,
    "mmsGrowth": -1.39,
    "revenue": 27737450,
    "mbGpDollars": 8914433,
    "mbGpMargin": 32.14,
    "mbGrowth": -2.55,
    "mbOutpaceMms": -1.16,
    "mmsOutpaceMarket": -6.6,
    "mbVsMmsGp": 12.07,
    "nbSales": 158339290,
    "summary": {
      "headline": "Strong margin leader with significant untapped market opportunity despite declining sales.",
      "pros": [
        "Superior 32.1% gross profit margin versus NB 20.1%",
        "Massive market size at $1.85B with only 15% penetration",
        "MMS holds 8.5% share in large, growing 4.9% market"
      ],
      "cons": [
        "MB sales declining 2.5% while market grows 4.9%",
        "Underperforming NB by 1.2% in growth rate trajectory",
        "Low 2.5% coverage suggests distribution or adoption barriers"
      ]
    }
  },
  {
    "id": 63,
    "category": "Personal Care",
    "tier": null,
    "penetration": 19.49,
    "coverage": 2.99,
    "totalMarket": 446874712,
    "marketGrowth": 7.36,
    "marketShare": 10.91,
    "mmsGpDollars": 12774115,
    "mmsGpMargin": 25.14,
    "mmsGrowth": 15.45,
    "revenue": 12296029,
    "mbGpDollars": 4758638,
    "mbGpMargin": 38.7,
    "mbGrowth": 12.89,
    "mbOutpaceMms": -2.56,
    "mmsOutpaceMarket": 6.41,
    "mbVsMmsGp": 13.56,
    "nbSales": 50803160,
    "summary": {
      "headline": "High-margin Personal Care with strong growth but limited market penetration needs acceleration",
      "pros": [
        "38.7% GP% significantly outperforms NB at 25.1%",
        "12.9% MB growth exceeds market 7.4% growth rate",
        "$12.3M sales base provides foundation for scaling"
      ],
      "cons": [
        "Only 19% penetration indicates substantial untapped customer base",
        "3.0% coverage is critically low for market reach",
        "Underperforming NB by 2.6% suggests competitive pressure despite higher margins"
      ]
    }
  },
  {
    "id": 64,
    "category": "Personal Protective Equipment",
    "tier": null,
    "penetration": 42.03,
    "coverage": 3.05,
    "totalMarket": 1606043409,
    "marketGrowth": -9.06,
    "marketShare": 6.61,
    "mmsGpDollars": 13114228,
    "mmsGpMargin": 27.62,
    "mmsGrowth": -34.7,
    "revenue": 34427947,
    "mbGpDollars": 14914090,
    "mbGpMargin": 43.32,
    "mbGrowth": -23.26,
    "mbOutpaceMms": 11.44,
    "mmsOutpaceMarket": -18.65,
    "mbVsMmsGp": 15.7,
    "nbSales": 47475471,
    "summary": {
      "headline": "Strong margin advantage offsets declining market and growth headwinds.",
      "pros": [
        "Significant GP% advantage: 43.3% vs NB 27.6%",
        "Market-leading MMS share at 6.6% in category",
        "Outpacing NB growth despite overall market decline"
      ],
      "cons": [
        "Steep MB decline of -23.3% year-over-year",
        "Shrinking market: -9.1% total category growth",
        "Low coverage at 3.0% suggests limited distribution"
      ]
    }
  },
  {
    "id": 65,
    "category": "Procedure Equipment (Sterilize",
    "tier": null,
    "penetration": 3.61,
    "coverage": 1.02,
    "totalMarket": 66185450,
    "marketGrowth": 3.94,
    "marketShare": 33.1,
    "mmsGpDollars": 5313026,
    "mmsGpMargin": 21.87,
    "mmsGrowth": -0.52,
    "revenue": 911077,
    "mbGpDollars": 207529,
    "mbGpMargin": 22.78,
    "mbGrowth": 4.71,
    "mbOutpaceMms": 5.23,
    "mmsOutpaceMarket": -3.94,
    "mbVsMmsGp": 0.91,
    "nbSales": 24292511,
    "summary": {
      "headline": "Strong MB growth momentum in underpenetrated market signals Tier 2 opportunity.",
      "pros": [
        "MB outpacing NB growth by 5.2 percentage points",
        "Champion category with proven MB sales traction",
        "Untapped potential with only 4% penetration rate",
        "Market growing at 3.9% with $66.2M total size"
      ],
      "cons": [
        "Low MB sales of $0.9M limits revenue impact",
        "Minimal market coverage at 1.0% suggests barriers",
        "Slim GP margin advantage of 0.9 points vs NB",
        "MMS already commanding 33.1% market share dominance"
      ]
    }
  },
  {
    "id": 66,
    "category": "Respiratory Therapy",
    "tier": null,
    "penetration": 14.52,
    "coverage": 2.12,
    "totalMarket": 1156244496,
    "marketGrowth": 2.73,
    "marketShare": 10.54,
    "mmsGpDollars": 30457721,
    "mmsGpMargin": 24.8,
    "mmsGrowth": 1.36,
    "revenue": 20858400,
    "mbGpDollars": 8347956,
    "mbGpMargin": 40.02,
    "mbGrowth": 14.14,
    "mbOutpaceMms": 12.78,
    "mmsOutpaceMarket": 0.11,
    "mbVsMmsGp": 15.22,
    "nbSales": 122800512,
    "summary": {
      "headline": "High-growth MB brand with massive untapped market opportunity.",
      "pros": [
        "Strong MB growth of 14.1% significantly outpacing NB",
        "Excellent gross profit margin of 40.0% versus NB 24.8%",
        "Low penetration (15%) and coverage (2.1%) indicate expansion potential"
      ],
      "cons": [
        "Modest $20.9M MB sales in large $1.16B market",
        "Overall market growth only 2.7% limits category tailwinds",
        "Low coverage suggests limited customer reach and distribution"
      ]
    }
  },
  {
    "id": 67,
    "category": "Rx - Asthma",
    "tier": null,
    "penetration": 10.81,
    "coverage": 2.87,
    "totalMarket": 65404146,
    "marketGrowth": -0.02,
    "marketShare": 24.92,
    "mmsGpDollars": 3837869,
    "mmsGpMargin": 21.24,
    "mmsGrowth": -1.04,
    "revenue": 2189590,
    "mbGpDollars": 704068,
    "mbGpMargin": 32.16,
    "mbGrowth": 9.54,
    "mbOutpaceMms": 10.58,
    "mmsOutpaceMarket": 1.55,
    "mbVsMmsGp": 10.92,
    "nbSales": 18073181,
    "summary": {
      "headline": "Strong MB growth and margins justify Tier 2 priority investment.",
      "pros": [
        "MB outpacing NB growth significantly at 10.6 percentage points",
        "High gross profit margin of 32.2% supports profitability",
        "Untapped potential with only 11% penetration indicates room",
        "Strategy Star status confirms positive MB vs NB dynamics"
      ],
      "cons": [
        "Flat market growth at -0.0% limits category expansion opportunity",
        "Low coverage at 2.9% constrains scaling potential currently",
        "MB sales only $2.2M represents modest absolute revenue base"
      ]
    }
  },
  {
    "id": 68,
    "category": "Rx-Anti-Infectives",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 2097409,
    "marketGrowth": 2.53,
    "marketShare": 77.12,
    "mmsGpDollars": 7001591,
    "mmsGpMargin": 18.91,
    "mmsGrowth": -0.95,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": 0.39,
    "mbVsMmsGp": null,
    "nbSales": 37023680,
    "summary": {
      "headline": "Tier 5: Zero MB presence in growing market with strong competitor hold.",
      "pros": [
        "Healthy market growth at 2.5% annually",
        "Significant market size of $2.1M provides opportunity",
        "Untapped potential quadrant suggests expansion room"
      ],
      "cons": [
        "MMS controls 77.1% market share dominance",
        "Zero MB sales and penetration currently",
        "Competitive gap requires substantial investment to enter"
      ]
    }
  },
  {
    "id": 69,
    "category": "Rx-Biological/Blood Rx",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 62986711,
    "marketGrowth": -0.96,
    "marketShare": 53.75,
    "mmsGpDollars": 7045419,
    "mmsGpMargin": 19.28,
    "mmsGrowth": -0.15,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": -1.06,
    "mbVsMmsGp": null,
    "nbSales": 36543441,
    "summary": {
      "headline": "Tier 5: No McKesson Brands sales in high-value market segment.",
      "pros": [
        "Large $63M market with established demand signals",
        "MMS holds strong 53.8% market share position",
        "Biological/blood category strategically important for healthcare"
      ],
      "cons": [
        "Zero MB penetration and sales despite market presence",
        "Negative market growth trajectory at -1.0% annually",
        "Competitor (NB) maintains 19.3% GP% advantage"
      ]
    }
  },
  {
    "id": 70,
    "category": "Rx-Cardiology",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 69049284,
    "marketGrowth": 4.92,
    "marketShare": 29.99,
    "mmsGpDollars": 7242212,
    "mmsGpMargin": 20.26,
    "mmsGrowth": -6.85,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": -10,
    "mbVsMmsGp": null,
    "nbSales": 35743679,
    "summary": {
      "headline": "Zero MB presence in growing $69M cardiology market represents significant untapped opportunity.",
      "pros": [
        "Large addressable market at $69.0M with healthy 4.9% growth",
        "MMS commands 30% market share indicating strong category presence",
        "Untapped Potential quadrant suggests high growth runway for MB",
        "NB competitor margin of 20.3% shows profitable category dynamics"
      ],
      "cons": [
        "Complete MB market absence signals potential competitive or capability gaps",
        "Zero penetration and coverage indicate significant go-to-market investment required",
        "Cannot assess MB growth trajectory without existing sales baseline",
        "NB competitors already established with demonstrated profitability and scale"
      ]
    }
  },
  {
    "id": 71,
    "category": "Rx-Core Vaccines",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 743388430,
    "marketGrowth": 27.35,
    "marketShare": 73.24,
    "mmsGpDollars": -1445572,
    "mmsGpMargin": -0.13,
    "mmsGrowth": 33.97,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": 6.63,
    "mbVsMmsGp": null,
    "nbSales": 1125773679,
    "summary": {
      "headline": "Tier 5: Zero MB sales in high-growth vaccine market.",
      "pros": [
        "Massive market opportunity at $743.4M annually",
        "Strong market growth momentum at 27.4% YoY",
        "High competitor engagement signals market viability"
      ],
      "cons": [
        "No McKesson Brands presence or sales history",
        "Dominant competitor (MMS) controls 73.2% share",
        "Negative NB gross profit indicates margin challenges"
      ]
    }
  },
  {
    "id": 72,
    "category": "Rx-Corticosteroids",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 271062960,
    "marketGrowth": -3.4,
    "marketShare": 55.11,
    "mmsGpDollars": 13526324,
    "mmsGpMargin": 9.92,
    "mmsGrowth": -4.45,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": -1.07,
    "mbVsMmsGp": null,
    "nbSales": 136349244,
    "summary": {
      "headline": "Tier 5: No McKesson Brands sales presence in declining market.",
      "pros": [
        "Large total market opportunity at $271.1M",
        "Strong MMS competitor presence indicates viable market",
        "Established category with defined customer base"
      ],
      "cons": [
        "Zero MB sales and zero penetration currently",
        "Market declining at -3.4% annually",
        "High barrier to entry against dominant competitor",
        "No MB growth trajectory established",
        "NB gross profit margin only 9.9%"
      ]
    }
  },
  {
    "id": 73,
    "category": "Rx-Cosmetic",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 3157990,
    "marketGrowth": 25.97,
    "marketShare": 40.55,
    "mmsGpDollars": 966367,
    "mmsGpMargin": 20.86,
    "mmsGrowth": 13.14,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": -7.05,
    "mbVsMmsGp": null,
    "nbSales": 4632182,
    "summary": {
      "headline": "Tier 5: No McKesson Brands sales in high-growth market.",
      "pros": [
        "Strong market growth at 26% year-over-year",
        "Large addressable market of $3.2M available",
        "MMS has significant 40.5% market share footprint"
      ],
      "cons": [
        "Zero MB sales and zero penetration currently",
        "Competitor NB brands entrenched with 20.9% margins",
        "No historical MB growth data to leverage"
      ]
    }
  },
  {
    "id": 74,
    "category": "Rx-Diabetes",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 46425,
    "marketGrowth": -10.85,
    "marketShare": 50.05,
    "mmsGpDollars": 1442608,
    "mmsGpMargin": 17.3,
    "mmsGrowth": -8.66,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": -11.77,
    "mbVsMmsGp": null,
    "nbSales": 8340009,
    "summary": {
      "headline": "No MB sales presence; market declining with strong competitor position.",
      "pros": [
        "Strong MMS market share at 50% indicates category relevance",
        "NB gross profit of 17.3% shows viable margin potential",
        "Untapped potential suggests significant growth opportunity ahead"
      ],
      "cons": [
        "Zero MB sales and penetration indicates complete market absence",
        "Negative market growth of -10.8% signals category headwinds",
        "No MB growth data limits ability to assess competitive viability"
      ]
    }
  },
  {
    "id": 75,
    "category": "Rx-Diagnostic Imaging",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 4068783,
    "marketGrowth": -8.81,
    "marketShare": 32.1,
    "mmsGpDollars": 11322381,
    "mmsGpMargin": 12.53,
    "mmsGrowth": 4.22,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": -4.65,
    "mbVsMmsGp": null,
    "nbSales": 90328987,
    "summary": {
      "headline": "Tier 5: Zero MB presence in declining market with strong competitor position.",
      "pros": [
        "Large addressable market at $4.1M",
        "MMS holds significant 32.1% market share",
        "Untapped potential for MB entry and growth"
      ],
      "cons": [
        "Market declining at -8.8% annually",
        "Zero MB sales and zero penetration currently",
        "NB competitor has established 12.5% gross profit"
      ]
    }
  },
  {
    "id": 76,
    "category": "Rx-General Rx",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 3037206,
    "marketGrowth": 85.01,
    "marketShare": 9.19,
    "mmsGpDollars": 2730756,
    "mmsGpMargin": 25.78,
    "mmsGrowth": -12.07,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": -78.16,
    "mbVsMmsGp": null,
    "nbSales": 10592669,
    "summary": {
      "headline": "Tier 5: No McKesson Brands sales despite significant market opportunity.",
      "pros": [
        "Large market size at $3.0M with strong 85% growth",
        "McKesson has 9.2% market share to leverage",
        "High competitor GP% of 25.8% shows profitability potential"
      ],
      "cons": [
        "Zero MB sales and zero penetration indicate no current presence",
        "Untapped potential requires significant investment to capture",
        "Competitive market with established non-brand players dominating"
      ]
    }
  },
  {
    "id": 77,
    "category": "Rx-Injectable Vitamins",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 38926472,
    "marketGrowth": 11.25,
    "marketShare": 22.42,
    "mmsGpDollars": -2100916,
    "mmsGpMargin": -16.67,
    "mmsGrowth": -0.22,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": -10.93,
    "mbVsMmsGp": null,
    "nbSales": 12606095,
    "summary": {
      "headline": "Tier 5: No McKesson Brands sales; untapped market opportunity.",
      "pros": [
        "Large $38.9M market with strong 11.3% growth",
        "MMS holds healthy 22.4% market share presence",
        "Zero MB sales means greenfield expansion opportunity"
      ],
      "cons": [
        "National Brands showing negative 16.7% gross profit",
        "MB has zero penetration and zero coverage currently",
        "Market dynamics unclear; NB profitability challenges concerning"
      ]
    }
  },
  {
    "id": 78,
    "category": "Rx-Mens Health",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": null,
    "marketGrowth": null,
    "marketShare": null,
    "mmsGpDollars": 554967,
    "mmsGpMargin": 17.47,
    "mmsGrowth": -17.24,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": null,
    "mbVsMmsGp": null,
    "nbSales": 3176001,
    "summary": {
      "headline": "Zero MB sales with untapped market potential suggests Tier 5 classification.",
      "pros": [
        "Positioned in high-growth mens health category",
        "Untapped potential quadrant indicates opportunity",
        "No existing MB sales means clean slate"
      ],
      "cons": [
        "Zero MB sales and zero penetration currently",
        "No market data available for category",
        "NB GP% at 17.5% shows competitive landscape"
      ]
    }
  },
  {
    "id": 79,
    "category": "Rx-Nervous System",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 255803699,
    "marketGrowth": 0.29,
    "marketShare": 46.74,
    "mmsGpDollars": 50647154,
    "mmsGpMargin": 27.28,
    "mmsGrowth": 0.37,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": 0.62,
    "mbVsMmsGp": null,
    "nbSales": 185646926,
    "summary": {
      "headline": "Tier 5: Zero MB sales despite substantial market opportunity.",
      "pros": [
        "Large total market size at $255.8M",
        "Strong MMS market share dominance at 46.7%",
        "Healthy NB gross profit margin at 27.3%"
      ],
      "cons": [
        "Complete absence of McKesson Brands sales presence",
        "Zero penetration and coverage indicates no market entry",
        "Untapped potential requires significant investment to compete"
      ]
    }
  },
  {
    "id": 80,
    "category": "Rx-Ophthalmic",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 28438149,
    "marketGrowth": 8.22,
    "marketShare": 63.36,
    "mmsGpDollars": 7590556,
    "mmsGpMargin": 20.87,
    "mmsGrowth": 3.88,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": 0.35,
    "mbVsMmsGp": null,
    "nbSales": 36377970,
    "summary": {
      "headline": "Tier 5: Zero McKesson Brands presence in growing ophthalmic market.",
      "pros": [
        "Large total market size of $28.4M with healthy 8.2% growth",
        "Strong MMS market dominance at 63.4% share indicates category importance",
        "Untapped potential offers greenfield opportunity for MB entry"
      ],
      "cons": [
        "No McKesson Brands sales or presence; complete market absence",
        "Competitor NB products already established with 20.9% gross profit",
        "Zero penetration and coverage metrics require significant launch investment"
      ]
    }
  },
  {
    "id": 81,
    "category": "Rx-Otc And Topicals",
    "tier": null,
    "penetration": 18.9,
    "coverage": 8.38,
    "totalMarket": 323909846,
    "marketGrowth": 6.11,
    "marketShare": 19.47,
    "mmsGpDollars": 33118719,
    "mmsGpMargin": 31.02,
    "mmsGrowth": 9.85,
    "revenue": 24872417,
    "mbGpDollars": 9276165,
    "mbGpMargin": 37.29,
    "mbGrowth": -2.53,
    "mbOutpaceMms": -12.39,
    "mmsOutpaceMarket": 0.72,
    "mbVsMmsGp": 6.27,
    "nbSales": 106759946,
    "summary": {
      "headline": "Tier 2: Strong position deteriorating; needs growth intervention urgently.",
      "pros": [
        "Solid $24.9M sales base with 37.3% gross profit margin",
        "Market-leading 19.5% share in $323.9M total addressable market",
        "Low coverage (8.4%) indicates significant expansion opportunity"
      ],
      "cons": [
        "Negative 2.5% MB growth while market grows 6.1%",
        "Lagging NB by 12.4 points; losing competitive ground",
        "Low penetration (19%) despite reassessment quadrant placement risk"
      ]
    }
  },
  {
    "id": 82,
    "category": "Rx-Rx Services",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 7737331,
    "marketGrowth": 5.25,
    "marketShare": 44.58,
    "mmsGpDollars": 1401637,
    "mmsGpMargin": 33.39,
    "mmsGrowth": 8.35,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": 4.61,
    "mbVsMmsGp": null,
    "nbSales": 4197879,
    "summary": {
      "headline": "Tier 5: Zero MB sales despite $7.7M market opportunity.",
      "pros": [
        "Large addressable market at $7.7M with healthy 5.3% growth",
        "Strong NB gross margin of 33.4% indicates profitable category",
        "MMS holds 44.6% market share showing category relevance"
      ],
      "cons": [
        "Complete absence of MB sales and penetration signals misalignment",
        "Untapped potential quadrant indicates strategic execution gap needed",
        "Zero coverage and 0% penetration require foundational category investment"
      ]
    }
  },
  {
    "id": 83,
    "category": "Rx-Specialty Rx",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 350550888,
    "marketGrowth": 17.56,
    "marketShare": 71.1,
    "mmsGpDollars": -2540229,
    "mmsGpMargin": -0.27,
    "mmsGrowth": 16.78,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": 5.59,
    "mbVsMmsGp": null,
    "nbSales": 944679232,
    "summary": {
      "headline": "Tier 5: Zero MB sales despite high-growth, large market opportunity.",
      "pros": [
        "Large $350.6M total market with strong 17.6% growth",
        "High MMS market share at 71.1% indicates category strength",
        "Untapped potential suggests significant growth opportunity ahead"
      ],
      "cons": [
        "Complete absence of MB sales and penetration signals no traction",
        "NB showing negative GP% indicates category profitability challenges",
        "Zero coverage means no existing customer base to leverage"
      ]
    }
  },
  {
    "id": 84,
    "category": "Rx-Ulcer Drugs",
    "tier": null,
    "penetration": 2.63,
    "coverage": 0.77,
    "totalMarket": 250694,
    "marketGrowth": 115.86,
    "marketShare": 34.4,
    "mmsGpDollars": 1537224,
    "mmsGpMargin": 35.67,
    "mmsGrowth": -13.81,
    "revenue": 116358,
    "mbGpDollars": 46455,
    "mbGpMargin": 39.92,
    "mbGrowth": 547.24,
    "mbOutpaceMms": 561.04,
    "mmsOutpaceMarket": 22.61,
    "mbVsMmsGp": 4.26,
    "nbSales": 4309873,
    "summary": {
      "headline": "Tier 2: Explosive MB growth with untapped market penetration opportunity.",
      "pros": [
        "Exceptional MB growth at 547.2% significantly outpacing NB",
        "Strong market tailwinds with 115.9% category growth rate",
        "Superior MB gross margin of 39.9% versus NB 35.7%"
      ],
      "cons": [
        "Very low penetration at 3% indicates limited market adoption",
        "Minimal MB sales base of $0.1M needs scaling",
        "Minimal coverage at 0.8% restricts growth potential currently"
      ]
    }
  },
  {
    "id": 85,
    "category": "Rx-Womens Health",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 2391119,
    "marketGrowth": -46.69,
    "marketShare": 57.52,
    "mmsGpDollars": -463242,
    "mmsGpMargin": -3.48,
    "mmsGrowth": -8.72,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": 31.43,
    "mbVsMmsGp": null,
    "nbSales": 13297055,
    "summary": {
      "headline": "Tier 5: Zero McKesson sales despite moderate market opportunity.",
      "pros": [
        "Strong MMS market share at 57.5% indicates category demand",
        "Untapped potential suggests growth opportunity if MB enters",
        "Moderate market size of $2.4M provides baseline revenue"
      ],
      "cons": [
        "Zero MB sales and penetration shows complete market absence",
        "Negative market growth of -46.7% indicates declining category",
        "Negative NB gross profit signals category-wide profitability challenges"
      ]
    }
  },
  {
    "id": 86,
    "category": "Services",
    "tier": null,
    "penetration": 0,
    "coverage": 0.61,
    "totalMarket": 2063354,
    "marketGrowth": -17.45,
    "marketShare": 81.58,
    "mmsGpDollars": 12471770,
    "mmsGpMargin": 91.88,
    "mmsGrowth": -3.74,
    "revenue": 125,
    "mbGpDollars": 125,
    "mbGpMargin": 100,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": -2.89,
    "mbVsMmsGp": 8.12,
    "nbSales": 13573469,
    "summary": {
      "headline": "Zero MB sales in shrinking market with minimal customer coverage.",
      "pros": [
        "High gross profit margin potential at 100%",
        "Untapped market segment with growth opportunity",
        "Low competition with 81.6% MMS market share"
      ],
      "cons": [
        "No existing McKesson Brands sales or customer relationships",
        "Market declining at 17.4% year-over-year rate",
        "Only 0.6% customer coverage despite market presence"
      ]
    }
  },
  {
    "id": 87,
    "category": "Sexual Health Molecular - NW",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 71955223,
    "marketGrowth": 4.69,
    "marketShare": 34.3,
    "mmsGpDollars": 5182380,
    "mmsGpMargin": 20.25,
    "mmsGrowth": 4.05,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": 2.98,
    "mbVsMmsGp": null,
    "nbSales": 25588516,
    "summary": {
      "headline": "Zero MB presence in large, growing market represents significant untapped opportunity.",
      "pros": [
        "Large $72M total market with healthy 4.7% growth trajectory",
        "MMS holds strong 34.3% market share demonstrating category strength",
        "Untapped Potential quadrant indicates clear expansion opportunity for MB"
      ],
      "cons": [
        "Zero MB sales and zero penetration across entire category",
        "NB competitors established with 20.3% gross profit margins",
        "No MB growth data limits ability to assess execution capability"
      ]
    }
  },
  {
    "id": 88,
    "category": "Sexual Health Molecular - W",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 13206373,
    "marketGrowth": 4.36,
    "marketShare": 23.56,
    "mmsGpDollars": 890757,
    "mmsGpMargin": 20.67,
    "mmsGrowth": null,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": null,
    "mbVsMmsGp": null,
    "nbSales": 4309675,
    "summary": {
      "headline": "Tier 5: Zero MB sales indicates no current McKesson Brands presence.",
      "pros": [
        "Large total market size at $13.2M provides opportunity",
        "Healthy market growth of 4.4% shows category momentum",
        "Strong NB gross profit margin of 20.7% demonstrates viability"
      ],
      "cons": [
        "Complete absence of MB sales and market penetration",
        "MMS already owns 23.6% share, significant competitor presence",
        "No historical MB growth data to assess potential"
      ]
    }
  },
  {
    "id": 89,
    "category": "Sexual Health Non-Molecular",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 29566990,
    "marketGrowth": 7.76,
    "marketShare": 43.88,
    "mmsGpDollars": 4470868,
    "mmsGpMargin": 27.33,
    "mmsGrowth": 12.26,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": 4.37,
    "mbVsMmsGp": null,
    "nbSales": 16357184,
    "summary": {
      "headline": "Tier 5: Zero MB sales in growing market with untapped potential.",
      "pros": [
        "Large total market size at $29.6M with healthy 7.8% growth",
        "Strong MMS market share of 43.9% demonstrates category viability",
        "Untapped potential quadrant suggests significant growth opportunity ahead"
      ],
      "cons": [
        "Complete absence of McKesson Brands sales and margin data",
        "Zero penetration and coverage indicate no current market presence",
        "Competitors gaining share while MB remains uninvested in category"
      ]
    }
  },
  {
    "id": 90,
    "category": "Skin & Surgical Prep",
    "tier": null,
    "penetration": 41.48,
    "coverage": 13.97,
    "totalMarket": 804361158,
    "marketGrowth": 6.42,
    "marketShare": 5.65,
    "mmsGpDollars": 10014779,
    "mmsGpMargin": 26.54,
    "mmsGrowth": 7.58,
    "revenue": 26750281,
    "mbGpDollars": 10964537,
    "mbGpMargin": 40.99,
    "mbGrowth": -10.39,
    "mbOutpaceMms": -17.97,
    "mmsOutpaceMarket": 0.43,
    "mbVsMmsGp": 14.45,
    "nbSales": 37734397,
    "summary": {
      "headline": "Strong margins and market position offset by significant MB decline.",
      "pros": [
        "High GP% advantage: 41.0% MB vs 26.5% NB",
        "Assortment Leader position with established market presence",
        "Large absolute sales base of $26.8M provides revenue foundation"
      ],
      "cons": [
        "Sharp MB sales decline of -10.4% year-over-year",
        "MB underperforming NB by -18.0% growth differential",
        "Low coverage at 14.0% indicates limited market penetration opportunity"
      ]
    }
  },
  {
    "id": 91,
    "category": "Skin Care",
    "tier": null,
    "penetration": 47.13,
    "coverage": 7.78,
    "totalMarket": 374534980,
    "marketGrowth": 5.43,
    "marketShare": 12.99,
    "mmsGpDollars": 9111434,
    "mmsGpMargin": 29.19,
    "mmsGrowth": 0.58,
    "revenue": 27827961,
    "mbGpDollars": 9269904,
    "mbGpMargin": 33.31,
    "mbGrowth": 11.64,
    "mbOutpaceMms": 11.06,
    "mmsOutpaceMarket": -7.14,
    "mbVsMmsGp": 4.12,
    "nbSales": 31217008,
    "summary": {
      "headline": "Strong growth and margin leader with significant expansion runway ahead.",
      "pros": [
        "MB growing 11.6% vs market 5.4%, outpacing NB by 11.1%",
        "33.3% GP margin exceeds NB by 410 basis points",
        "Assortment Leader with high penetration at 47% of accounts"
      ],
      "cons": [
        "Low coverage at 7.8% limits total market opportunity capture",
        "MB represents only 7.4% of $374.5M total market",
        "Significant whitespace despite strong performance trajectory"
      ]
    }
  },
  {
    "id": 92,
    "category": "Specialty Dressings",
    "tier": null,
    "penetration": 26,
    "coverage": 4.98,
    "totalMarket": 1864151874,
    "marketGrowth": 5.53,
    "marketShare": 9.91,
    "mmsGpDollars": 41370603,
    "mmsGpMargin": 24.57,
    "mmsGrowth": 0.12,
    "revenue": 59161275,
    "mbGpDollars": 23775381,
    "mbGpMargin": 40.19,
    "mbGrowth": 3.64,
    "mbOutpaceMms": 3.52,
    "mmsOutpaceMarket": -4.58,
    "mbVsMmsGp": 15.62,
    "nbSales": 168404836,
    "summary": {
      "headline": "Tier 2: Strong performer with selective market opportunity and margin advantage.",
      "pros": [
        "Significant margin advantage: 40.2% GB vs 24.6% NB",
        "MB outpacing NB growth by 3.5 percentage points",
        "McKesson Brands Champions in growth dynamics framework",
        "Substantial revenue base at $59.2M with healthy 3.6% growth"
      ],
      "cons": [
        "Low penetration at 26% limits expansion potential currently",
        "Minimal coverage at 5.0% indicates selective distribution only",
        "Market growth 5.5% outpacing MB growth 3.6% slightly",
        "Large addressable market $1864.2M suggests untapped opportunity"
      ]
    }
  },
  {
    "id": 93,
    "category": "Sterile Drapes & Gowns",
    "tier": null,
    "penetration": 41.97,
    "coverage": 10.35,
    "totalMarket": 476017252,
    "marketGrowth": 6.18,
    "marketShare": 3.99,
    "mmsGpDollars": 3793493,
    "mmsGpMargin": 28.13,
    "mmsGrowth": -10.47,
    "revenue": 9753190,
    "mbGpDollars": 3980938,
    "mbGpMargin": 40.82,
    "mbGrowth": 16.44,
    "mbOutpaceMms": 26.91,
    "mmsOutpaceMarket": -17.51,
    "mbVsMmsGp": 12.69,
    "nbSales": 13486210,
    "summary": {
      "headline": "Strong MB growth and margins warrant Tier 1 despite modest market coverage.",
      "pros": [
        "MB growing 16.4% with 26.9pp NB outpacing advantage",
        "40.8% gross profit margin significantly exceeds NB at 28.1%",
        "Assortment Leader with Champion growth dynamics position"
      ],
      "cons": [
        "Low 10.3% coverage limits category penetration upside potential",
        "4.0% MMS market share leaves substantial expansion room",
        "42% penetration indicates untapped customer segment opportunity"
      ]
    }
  },
  {
    "id": 94,
    "category": "Sterilization",
    "tier": null,
    "penetration": 37.67,
    "coverage": 3.89,
    "totalMarket": 756730684,
    "marketGrowth": -0.96,
    "marketShare": 8.18,
    "mmsGpDollars": 11031034,
    "mmsGpMargin": 29.05,
    "mmsGrowth": -0.95,
    "revenue": 22955250,
    "mbGpDollars": 10212507,
    "mbGpMargin": 44.49,
    "mbGrowth": 1.78,
    "mbOutpaceMms": 2.73,
    "mmsOutpaceMarket": 2.68,
    "mbVsMmsGp": 15.44,
    "nbSales": 37976220,
    "summary": {
      "headline": "Strong margin and growth momentum offset low penetration and shrinking market.",
      "pros": [
        "15.4pp GP% advantage over NB drives profitability",
        "MB outpacing NB growth by 2.7pp shows momentum",
        "Strategy Star positioning indicates favorable growth dynamics"
      ],
      "cons": [
        "38% penetration leaves significant untapped customer base",
        "Declining market (-1.0%) limits overall category growth",
        "3.9% coverage severely restricts distribution reach potential"
      ]
    }
  },
  {
    "id": 95,
    "category": "Surface Disinfection",
    "tier": null,
    "penetration": 12.18,
    "coverage": 2.81,
    "totalMarket": 706504192,
    "marketGrowth": 6.34,
    "marketShare": 9.58,
    "mmsGpDollars": 21136002,
    "mmsGpMargin": 27.78,
    "mmsGrowth": 4.38,
    "revenue": 10553154,
    "mbGpDollars": 4081151,
    "mbGpMargin": 38.67,
    "mbGrowth": 2.75,
    "mbOutpaceMms": -1.62,
    "mmsOutpaceMarket": -1.4,
    "mbVsMmsGp": 10.89,
    "nbSales": 76074239,
    "summary": {
      "headline": "High-margin growth opportunity with significant untapped market potential.",
      "pros": [
        "Strong 38.7% gross profit margin well above NB",
        "Large addressable market at $706.5M with 6.3% growth",
        "Solid $10.6M MB sales base to build upon"
      ],
      "cons": [
        "MB growth trailing NB by 1.6 percentage points",
        "Low 12% penetration indicates customer adoption challenges",
        "Minimal 2.8% coverage suggests limited distribution reach"
      ]
    }
  },
  {
    "id": 96,
    "category": "Surgical Disposables",
    "tier": null,
    "penetration": 9.85,
    "coverage": 2.02,
    "totalMarket": 862418376,
    "marketGrowth": 5.73,
    "marketShare": 2.7,
    "mmsGpDollars": 7104742,
    "mmsGpMargin": 28.83,
    "mmsGrowth": -2.63,
    "revenue": 2691811,
    "mbGpDollars": 1307823,
    "mbGpMargin": 48.59,
    "mbGrowth": -3.37,
    "mbOutpaceMms": -0.74,
    "mmsOutpaceMarket": -7.01,
    "mbVsMmsGp": 19.76,
    "nbSales": 24645245,
    "summary": {
      "headline": "High-margin brand with growth headwinds needs market penetration acceleration.",
      "pros": [
        "Strong 48.6% gross profit margin versus NB 28.8%",
        "Significant untapped potential in low 10% penetration rate",
        "Large addressable market at $862.4M total market size"
      ],
      "cons": [
        "Declining MB sales at -3.4% year-over-year trend",
        "Underperforming NB growth by -0.7 percentage points",
        "Very low 2.0% coverage limits market opportunity reach"
      ]
    }
  },
  {
    "id": 97,
    "category": "Surgical Equipment/Accessories",
    "tier": null,
    "penetration": 34.2,
    "coverage": 3.86,
    "totalMarket": 718797837,
    "marketGrowth": 4.26,
    "marketShare": 3.69,
    "mmsGpDollars": 6419264,
    "mmsGpMargin": 31.84,
    "mmsGrowth": -0.21,
    "revenue": 10480477,
    "mbGpDollars": 4245321,
    "mbGpMargin": 40.51,
    "mbGrowth": 8.27,
    "mbOutpaceMms": 8.48,
    "mmsOutpaceMarket": -4.59,
    "mbVsMmsGp": 8.67,
    "nbSales": 20163411,
    "summary": {
      "headline": "High-growth MB champion with strong margins but limited market reach.",
      "pros": [
        "MB significantly outpacing NB growth by 8.5 percentage points",
        "Superior gross profit margin of 40.5% vs NB 31.8%",
        "Strong MB growth rate of 8.3% exceeds market growth"
      ],
      "cons": [
        "Low penetration at 34% indicates untapped customer potential",
        "Coverage severely limited at 3.9% across account base",
        "Small absolute sales base limits scaling revenue impact"
      ]
    }
  },
  {
    "id": 98,
    "category": "Surgical Instruments",
    "tier": null,
    "penetration": 28.13,
    "coverage": 2.35,
    "totalMarket": 1671297342,
    "marketGrowth": 2.62,
    "marketShare": 5.49,
    "mmsGpDollars": 21914451,
    "mmsGpMargin": 29.81,
    "mmsGrowth": 3.61,
    "revenue": 28770623,
    "mbGpDollars": 12495410,
    "mbGpMargin": 43.43,
    "mbGrowth": 2.93,
    "mbOutpaceMms": -0.69,
    "mmsOutpaceMarket": 0.99,
    "mbVsMmsGp": 13.62,
    "nbSales": 73508816,
    "summary": {
      "headline": "Tier 2: Strong margin business with selective market penetration needing coverage expansion",
      "pros": [
        "Superior 43.4% gross profit margin versus NB at 29.8%",
        "MB growth slightly positive at 2.9% in modest market",
        "Selective Winner positioning indicates targeted customer strength"
      ],
      "cons": [
        "Low 28% penetration leaves significant untapped customer base",
        "Critically low 2.4% coverage limits market reach potential",
        "MB underperforming NB growth by 0.7 percentage points"
      ]
    }
  },
  {
    "id": 99,
    "category": "Table Paper",
    "tier": null,
    "penetration": 94.65,
    "coverage": 23.45,
    "totalMarket": 79015202,
    "marketGrowth": 10.9,
    "marketShare": 41.52,
    "mmsGpDollars": 697980,
    "mmsGpMargin": 28.7,
    "mmsGrowth": 2.99,
    "revenue": 42995063,
    "mbGpDollars": 14926126,
    "mbGpMargin": 34.72,
    "mbGrowth": 8.37,
    "mbOutpaceMms": 5.38,
    "mmsOutpaceMarket": -8.81,
    "mbVsMmsGp": 6.02,
    "nbSales": 2432377,
    "summary": {
      "headline": "Tier 1: Market leader with strong MB growth and GP advantage.",
      "pros": [
        "Dominant 41.5% market share with $43.0M MB sales",
        "MB outpacing NB growth by 5.4 percentage points",
        "Superior 34.7% MB GP vs 28.7% NB GP margin",
        "Exceptional 95% penetration across customer base"
      ],
      "cons": [
        "Low 23.4% coverage limits growth headroom",
        "Market growth slowing at 10.9% YoY",
        "MB growth at 8.4% below market expansion rate",
        "High penetration leaves limited new customer acquisition"
      ]
    }
  },
  {
    "id": 100,
    "category": "Tapes/Wraps",
    "tier": null,
    "penetration": 59.19,
    "coverage": 6.09,
    "totalMarket": 516772161,
    "marketGrowth": 3.64,
    "marketShare": 13.01,
    "mmsGpDollars": 9620605,
    "mmsGpMargin": 29.83,
    "mmsGrowth": -6.29,
    "revenue": 46792693,
    "mbGpDollars": 20690538,
    "mbGpMargin": 44.22,
    "mbGrowth": 7.3,
    "mbOutpaceMms": 13.59,
    "mmsOutpaceMarket": -8.59,
    "mbVsMmsGp": 14.39,
    "nbSales": 32256630,
    "summary": {
      "headline": "Strong MB growth and margins justify Tier 1 priority despite moderate market penetration.",
      "pros": [
        "MB outpacing NB by 13.6% signals strong category momentum",
        "44.2% GP% significantly exceeds NB at 29.8%",
        "McKesson Brands Champions status with 7.3% growth rate"
      ],
      "cons": [
        "59% penetration leaves 41% untapped customer opportunity",
        "6.1% coverage indicates limited shelf presence expansion",
        "13% market share suggests competitive intensity in category"
      ]
    }
  },
  {
    "id": 101,
    "category": "Textiles",
    "tier": null,
    "penetration": 70.23,
    "coverage": 6.16,
    "totalMarket": 798611978,
    "marketGrowth": 9.11,
    "marketShare": 7.2,
    "mmsGpDollars": 6269467,
    "mmsGpMargin": 27.48,
    "mmsGrowth": -6.87,
    "revenue": 53834410,
    "mbGpDollars": 22271821,
    "mbGpMargin": 41.37,
    "mbGrowth": 4.97,
    "mbOutpaceMms": 11.84,
    "mmsOutpaceMarket": -15.67,
    "mbVsMmsGp": 13.89,
    "nbSales": 22816969,
    "summary": {
      "headline": "High-margin leader with strong penetration but limited growth headroom.",
      "pros": [
        "Market-leading 41.4% gross profit margin vs NB 27.5%",
        "Exceptional penetration at 70% shows customer acceptance",
        "MB significantly outpacing NB growth by 11.8 points"
      ],
      "cons": [
        "Modest 5.0% MB growth in 9.1% growing market",
        "Very low 6.2% coverage limits expansion opportunity",
        "Modest $53.8M sales in large $798.6M market"
      ]
    }
  },
  {
    "id": 102,
    "category": "Therapy Massagers",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 145920,
    "marketGrowth": 91.57,
    "marketShare": 0.17,
    "mmsGpDollars": 713,
    "mmsGpMargin": 39.84,
    "mmsGrowth": -37.44,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": -129.45,
    "mbVsMmsGp": null,
    "nbSales": 1789,
    "summary": {
      "headline": "High-growth market with zero MB presence presents major opportunity.",
      "pros": [
        "Explosive 91.6% market growth indicates strong category momentum",
        "Untapped potential with 0% penetration and no MB sales",
        "Healthy 39.8% NB gross margin shows category profitability"
      ],
      "cons": [
        "Zero McKesson Brands sales and market share currently",
        "Tiny $0.1M total market limits revenue upside potential",
        "No baseline data to assess competitive positioning or feasibility"
      ]
    }
  },
  {
    "id": 103,
    "category": "Training Equipment & Supplies",
    "tier": null,
    "penetration": 0,
    "coverage": 0,
    "totalMarket": 9200632,
    "marketGrowth": 15.72,
    "marketShare": 0.04,
    "mmsGpDollars": 1616364,
    "mmsGpMargin": 30.7,
    "mmsGrowth": -0.66,
    "revenue": 0,
    "mbGpDollars": 0,
    "mbGpMargin": 0,
    "mbGrowth": null,
    "mbOutpaceMms": null,
    "mmsOutpaceMarket": null,
    "mbVsMmsGp": null,
    "nbSales": 5264296,
    "summary": {
      "headline": "Zero MB presence in growing market signals untapped opportunity.",
      "pros": [
        "Strong market growth at 15.7% year-over-year",
        "Substantial $9.2M total addressable market available",
        "Healthy NB gross margin of 30.7% shows profitability",
        "Untapped potential quadrant indicates greenfield opportunity"
      ],
      "cons": [
        "Zero McKesson sales indicates competitive disadvantage",
        "No current market share or customer base established",
        "Requires significant investment to build capabilities",
        "Competitors likely entrenched in growing category"
      ]
    }
  },
  {
    "id": 104,
    "category": "Underpads, Pads & Liners",
    "tier": null,
    "penetration": 40.3,
    "coverage": 5.24,
    "totalMarket": 808609235,
    "marketGrowth": 6.91,
    "marketShare": 14.87,
    "mmsGpDollars": 16424319,
    "mmsGpMargin": 18.49,
    "mmsGrowth": 0.89,
    "revenue": 59965180,
    "mbGpDollars": 17435636,
    "mbGpMargin": 29.08,
    "mbGrowth": 9.68,
    "mbOutpaceMms": 8.78,
    "mmsOutpaceMarket": -5.36,
    "mbVsMmsGp": 10.59,
    "nbSales": 88834684,
    "summary": {
      "headline": "Strong MB growth and margins warrant Tier 1 despite modest market penetration.",
      "pros": [
        "MB significantly outpacing NB growth by 8.8 percentage points",
        "Superior gross profit margin of 29.1% versus NB at 18.5%",
        "Assortment leader position with proven market competitiveness"
      ],
      "cons": [
        "Low penetration at 40% indicates untapped customer potential",
        "Minimal coverage at 5.2% limits market share expansion",
        "MMS market share of 14.9% suggests intense competitive pressure"
      ]
    }
  },
  {
    "id": 105,
    "category": "Urology",
    "tier": null,
    "penetration": 11.14,
    "coverage": 4.32,
    "totalMarket": 1124011110,
    "marketGrowth": 14.83,
    "marketShare": 6.97,
    "mmsGpDollars": 21124428,
    "mmsGpMargin": 19.33,
    "mmsGrowth": 4.85,
    "revenue": 13702292,
    "mbGpDollars": 5412692,
    "mbGpMargin": 39.5,
    "mbGrowth": 15.68,
    "mbOutpaceMms": 10.83,
    "mmsOutpaceMarket": -10.64,
    "mbVsMmsGp": 20.17,
    "nbSales": 109284136,
    "summary": {
      "headline": "Tier 2: High-growth champion with significant untapped market expansion opportunity.",
      "pros": [
        "MB outpacing NB growth by 10.8 percentage points",
        "Strong 39.5% gross profit margin versus 19.3% NB",
        "15.7% MB growth in 14.8% expanding market",
        "Low 11% penetration indicates substantial growth runway"
      ],
      "cons": [
        "Very low 4.3% coverage limits addressable customer base",
        "Only $13.7M sales against $1.124B market opportunity",
        "MMS captures just 7.0% of large market",
        "Untapped potential requires significant resource investment"
      ]
    }
  },
  {
    "id": 106,
    "category": "Wound Closure",
    "tier": null,
    "penetration": 21.3,
    "coverage": 1.86,
    "totalMarket": 2541270241,
    "marketGrowth": 2.26,
    "marketShare": 4.48,
    "mmsGpDollars": 24728617,
    "mmsGpMargin": 25.41,
    "mmsGrowth": -1.8,
    "revenue": 26341717,
    "mbGpDollars": 11373290,
    "mbGpMargin": 43.18,
    "mbGrowth": 4.64,
    "mbOutpaceMms": 6.45,
    "mmsOutpaceMarket": -4.15,
    "mbVsMmsGp": 17.77,
    "nbSales": 97335506,
    "summary": {
      "headline": "High-margin champion with strong growth but limited market penetration opportunity.",
      "pros": [
        "MB outpacing NB growth by 6.5 percentage points significantly",
        "43.2% gross profit margin substantially exceeds NB at 25.4%",
        "$26.3M sales base with 4.6% growth momentum year-over-year"
      ],
      "cons": [
        "Only 21% penetration indicates significant untapped customer opportunity",
        "1.9% coverage extremely low relative to total addressable market",
        "4.5% MMS market share leaves substantial competitive ground uncovered"
      ]
    }
  }
];

export const EXPECTED_COLUMNS = {
  category:         ['category level 2', 'l2 categories', 'l2 category',
                     'level 2 categories', 'level 2',
                     'category', 'product category', 'product name', 'item', 'item name',
                     'description', 'name', 'product', 'brand', 'segment',
                     'sub category', 'subcategory'],
  tier:             ['tier', 'priority tier', 'tier level', 'priority', 'ranking'],
  revenue:          ['mb sales $m', 'mb sales', 'total l12m sales', 'total sales',
                     'l12m sales', 'total revenue', 'net sales', 'revenue', 'sales'],
  mbGpDollars:      ['mb gp $m', 'mb gp$', 'mb gp dollars', 'mb gross profit', 'mb gp',
                     'total l12m mckb sales', 'mckb sales', 'l12m mckb sales',
                     'gp$', 'gp dollars', 'gross profit $', 'gross profit dollars',
                     'gross profit', 'gp amount'],
  mbGpMargin:       ['mb gp %', 'mb gp%', 'mb gp margin', 'mb gross margin', 'mb margin',
                     'mckb %', 'mckb%', 'mckb pct', 'mckb share',
                     'new mck %', 'new mck%',
                     'gp%', 'gp margin', 'gross margin', 'gross margin %',
                     'margin %', 'margin percent', 'gp rate'],
  mmsGpDollars:     ['mms gp $m', 'mms gp$', 'mms gp dollars', 'mms gross profit', 'mms gp',
                     'nb gp $m', 'nb gp$', 'nb gp dollars', 'nb gross profit', 'nb gp',
                     'med surg gp', 'medical surgical gp'],
  mmsGpMargin:      ['mms gp %', 'mms gp margin', 'mms gross margin',
                     'nb gp %', 'nb gp margin', 'nb gross margin'],
  penetration:      ['penetration', 'penetration %', 'pen %', 'pen',
                     'account penetration', 'acct pen', '% penetration'],
  coverage:         ['coverage', 'coverage %', 'cov %', '% coverage',
                     'portfolio coverage', 'sku coverage', 'line coverage',
                     'distribution coverage', 'dist coverage'],
  totalMarket:      ['total market $m', 'total market size $m', 'total market', 'market size $m',
                     'market size', 'tam $m', 'tam', 'addressable market $m', 'addressable market'],
  marketGrowth:     ['total market growth %', 'total market growth', 'market growth %',
                     'market growth', 'growth rate', 'growth %', 'growth rate %',
                     'market growth rate', 'yoy growth', 'yoy %', 'growth'],
  marketShare:      ['mms market share %', 'mms market share', 'mms share %',
                     'market share', 'relative market share', 'rel. market share',
                     'share', 'rms', 'rel market share', 'mkt share'],
  mbOutpaceMms:     ['mb outpace mms %', 'mb outpace mms', 'mb outpace nb %',
                     'mb outpace nb', 'mb vs mms growth', 'mb outpace'],
  mmsOutpaceMarket: ['mms outpace market %', 'mms outpace market', 'mms vs market growth',
                     'mms outpace market growth', 'mms outpace',
                     'nb outpace non-pl market', 'nb outpace non-pl', 'nb outpace market',
                     'nb outpace market %', 'nb outpace market growth', 'nb outpace'],
  mmsGrowth:        ['mms growth', 'mms growth %', 'nb growth', 'nb growth %'],
  mbGrowth:         ['mb growth', 'mb growth %'],
  nbSales:          ['nb sales $', 'nb sales $m', 'nb sales', 'national brand sales $',
                     'nb sales dollars', 'nb revenue', 'nb revenue $m'],
  mbVsMmsGp:        ['mb gp higher than mms gp %', 'mb gp higher than mms gp',
                     'mb gp higher than nb gp %', 'mb gp higher than nb gp',
                     'mb vs mms gp', 'mb vs nb gp', 'mb gp higher', 'mb higher than mms'],
};
